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Abstract 
Radiation therapy is a main component of treatment for many lung cancer patients. However, 
the respiratory motion can cause inaccuracies in radiation delivery that can lead to treatment 
complications. In addition, the radiation-induced damage to healthy tissue limits the 
effectiveness of radiation treatment. Motion management methods have been developed to 
increase the accuracy of radiation delivery, and functional avoidance treatment planning has 
emerged to help reduce the chances of radiation-induced toxicity. In this work, we have 
developed biomechanical model-based techniques for tumor motion estimation, as well as 
lung functional imaging. The proposed biomechanical model accurately estimates lung and 
tumor motion/deformation by mimicking the physiology of respiration, while accounting for 
heterogeneous changes in the lung mechanics caused by COPD, a common lung cancer 
comorbidity. A biomechanics-based image registration algorithm is developed and is 
combined with an air segmentation algorithm to develop a 4DCT-based ventilation imaging 
technique, with potential applications in functional avoidance therapies.  
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Summary for Lay Audience 
Lung cancer is the leading cause of cancer-related death in Canada. Radiation therapy is a 
main component of treatment for many lung cancer patients, in which high-energy beams are 
planned to target the tumor cells and destroy them.  
Both the lung and the tumor can move and deform during the radiation therapy as the patient 
breathes. If not accounted for, the motion of the tumor can considerably reduce the 
effectiveness of treatment. An ideal solution is to develop a system that can track the tumor 
in real-time and guide the radiation delivery accordingly. This tracking system requires 
accurate estimation of the tumor’s location and shape. Currently, four-dimensional computed 
tomography (4DCT) scans of the patients are used to plan the radiation delivery. We have 
developed a technique for estimating tumor motion/deformation by modeling the breathing 
mechanics using 4DCT scans. Our biomechanical model mimics lung physiology and is 
driven by the pressure and diaphragm motion present during a breathing cycle. Chronic 
obstructive pulmonary disease (COPD), is a progressive lung disease that commonly coexists 
with lung cancer and affects the lung mechanics in a heterogeneous manner. By 
incorporating these heterogeneous changes in the lung mechanics into our model, we 
achieved high accuracies for tumor motion/deformation estimation.  
Radiation treatment planning aims at maximizing the tumor dose while minimizing the 
healthy lung tissue exposure to radiation. Considering the heterogeneity in the lung function 
present in cancer patients (due to COPD and/or smoking), the outcome of radiation therapy 
can be improved by planning the radiation beam to deliberately avoid the well-functioning 
regions in the lung and instead pass through the already poorly-functioning regions. This 
method of planning is called functional avoidance and requires regional information on lung 
function that is usually obtained using magnetic resonance (MR) or nuclear medicine 
imaging. We have developed a 4DCT-based technique for imaging the regional ventilation, 
as a surrogate for lung function. 4DCT is a cost effective and accessible alternative to the 
current modalities. Our ventilation imaging method utilizes our accurate lung biomechanical 
model to find the regional change in the air volume, i.e. ventilation. Results show good 
agreement with MR-based functional images. 
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Chapter 1  
1 « Introduction» 
Lung cancer remains the leading cause of cancer-related deaths among men and women 
in Canada (1). Effectiveness of radiation therapy, as a main component of lung cancer 
treatment in many patients, may be reduced by uncertainties caused by respiratory motion 
and damage to healthy tissues. Respiratory motion compensation methods have emerged 
as potential solution for the former (2,3), and functional avoidance techniques have been 
developed to alleviate the latter (4,5). In this thesis, we describe biomechanical model-
based techniques for motion estimation and functional imaging to help improving the 
effectiveness of radiation therapy.  
1.1 « Lung Cancer » 
1.1.1 Statistics 
Cancer is the leading cause of death in Canada, with approximately 1 in 2 men and 1 in 
2.2 women expected to develop cancer in their lifetime (1). Lung and bronchus (referred 
to as lung for brevity), colorectal, breast, and prostate cancers are the most commonly 
diagnosed cancer types in Canada. They are responsible for about 50% of all cancer 
deaths in 2017 (Figure 1-1) (6). As shown in Figure 1-1, with incidence rates higher than 
all other cancer types, lung cancer kills more people than colorectal, breast, and prostate 
cancers combined (1). The World Health Organization estimates that lung cancer is the 
cause of 1.59 million deaths globally per year, with 71% of them caused by smoking (7). 
The 5-year survival rate of lung cancer is only 19% (Figure 1-1).  
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This rate is dependent on the type of the lung cancer (small cell lung cancer (SCLC) or 
non-small cell lung cancer (NSCLC)) and the stage at which it is detected (1).  For 
example, estimates of five-year survival rates range from 1% to 10% across the substages 
of stage IV, and from 68% to 92% for the substages of stage I. Five-year survival 
estimates are lower for SCLC: 2% for stage IV and 31% for stage I (1). NSCLC accounts 
for more than 80% of lung cancer cases and has three major histologic subtypes that are 
categorized by the cell type from which the disease originates (8). 1) Adenocarcinoma 
starts in glandular cells, is usually located along the outer edges of the lung and is more 
common among women and non-smokers. 2) Squamous cell (or epidermoid) carcinoma 
starts from squamous cells, usually occurs in one of the main airways or in the central 
part of the lung and is strongly associated with smoking. 3) Large cell lung cancer is 
distinguished from SCLC by the large cancer cells size, and is often found in the 
periphery, and are more commonly diagnosed in men (8). Figure 1-2 shows the incidence 
of different lung cancer types (8,9). 
Figure 1-1. Lung cancer annual incidence, annual deaths, and 5-yeas survival rate 
statistics (1). 
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Figure 1-2. Relative incidence of different lung cancer types (9). 
1.1.2 Comorbidities: Chronic Obstructive Pulmonary Disease  
Chronic obstructive pulmonary disease (COPD), is a progressive lung disease that fatally 
deteriorates the lung function over time. COPD is the 4th most common cause of 
hospitalization among men and the 6th most common cause of hospitalization among 
women in Canada. COPD is the only chronic disease with increasing mortality and is 
estimated that it will be the 3rd leading cause of death worldwide by 2020 (10,11).  
The damage to the lungs in COPD is caused by exogeneous (caused by smoking) or 
endogenous oxidative stress, protease activity, autoantibody expression, and 
inflammatory cytokine release. These will cause several pulmonary manifestations, 
including alveoli wall damage (emphysema) and small airways disease (SAD), which 
will in turn cause air trapping and lung hyperinflation (12).  
Emphysema is pathologically described as permanent destruction of the alveoli walls, 
resulting in abnormal permanent enlargement of the air spaces distal to the terminal 
bronchioles (Figure 1-3). The destruction of the alveoli walls results in a decrease in the 
surface area available for exchange of O2 and CO2 to and from the capillaries (Figure 
1-3) (12). As shown in Figure 1-3 emphysema can be detected on computed tomography 
(CT) scans taken at full inspiration. The extent of emphysema can also be quantified 
using information derived from CT scan (13). 
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The patterns of emphysema observed in COPD are classified to centrilobular (airways 
destruction observed around the terminal bronchioles) and panlobular or panacinar 
(homogeneous airways destruction) (12,14). 
The airways with internal diameter smaller than 2 mm that extend from the 8th generation 
airways to the alveoli are classified as “small airways” (Figure 1-4). The cross-sectional 
surface area of the small airways is far greater than that of the large airways; however, 
they are responsible for only about 10% of the total airways’ resistance. Therefore, 
conventional pulmonary function tests may fail to detect abnormalities even when 
extensive disease is present in the small airways. In COPD, SAD mostly involves 
remodeling of the small airways, along with an increase in airways smooth muscle, 
destruction of alveolar attachments, and airway wall fibrosis (12,15). Assessment of SAD 
is challenging. A number of invasive and non-invasive methods have been reported for 
diagnosis and assessment of SAD. The invasive methods are based on histological 
analysis on transbronchial biopsy samples or surgically resected specimens(16).  
Figure 1-3. Emphysema. (a) Schematic comparing the alveoli structure in healthy and 
emphysematous tissues. The breakdown of the airway walls enlarges the alveoli and 
decreases the effective surface area for O2 and CO2 exchange. Reproduced with 
permission. Copyright 2019, Mayo Foundation for Medical Education and Research. (b) 
Regions affected by emphysema can be detected on CT scans as low attenuation areas 
(sample regions enclosed in red ellipses).  
(a) (b) 
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The non-invasive methods are based on imaging or physiological assessments (15). 
Imaging is an attractive option for assessment of SAD, and COPD in general, especially 
in the case of lung cancer patients where imaging of the lungs is part of the routine care 
in most centers. Standard CT, high resolution CT, and hyperpolarized gas magnetic 
resonance imaging (MRI) are widely used for diagnosis, and assessment of disease 
progression and treatment response (16). Single-proton emission computed tomography 
(SPECT) and proton emission tomography (PET) can also be used for characterization of 
COPD, as they provide more insight into ventilation-perfusion relationships in the 
peripheral lung regions (17,18).  
1.1.3 Lung Cancer and COPD 
More than 65% of lung cancer patients also suffer from COPD (11,19). Beside the fact 
that smoking has proven to be a cause for both COPD and lung cancer, there is increasing 
evidence that links these two diseases beyond the one common etiology. Lung cancer is 
Figure 1-4. The classification of airways to large and small airways based on branching 
and diameter. The acinar zone is where the gas exchange happens, and it starts from 
terminal bronchioles. Reproduced with permission (15). Copyright 2012, Taylor & 
Francis.   
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up to 5 times more likely to affect smokers with COPD than smokers with normal lung 
function (20). A 2- to 6-fold higher risk of lung cancer in COPD patients have been 
reported to be regardless of smoking habits (21,22). Common mechanisms in COPD and 
lung cancer, such as premature aging in the lungs, common pathogenic factors, or genetic 
predispositions to either disease was explored as possible explanations for the high 
coexistence of lung cancer and COPD (21). COPD is known as an independent risk factor 
for lung cancer, respiratory-related complications, and postoperative recurrence of 
NSCLC (19). A number of previous studies have reported that coexisting COPD leads to 
poor prognosis for lung cancer (11,19).  
1.2 « Lung Cancer Treatment » 
The treatment strategy for lung cancer depends on factors such as the subtype and stage 
of the malignancy, histology, patient’s age, comorbidities, and patient’s preference. 
Comprehensive guidelines for diagnosis, staging, risk assessment, and treatment have 
been developed and are used in clinical practice for optimal outcome (23,24). Stage 
grouping of the malignant tumors according to the TNM guide is based on the extent of 
the primary tumor (denoted by T), regional lymph node metastasis (N), and distant 
metastasis (M) (Table 1-1). Treatment can be either or a combination of surgery, 
immunotherapy, chemotherapy, targeted therapy, and radiation therapy. Some treatment 
strategies are preferred over the others for different stages. A summary of recommended 
treatment strategies based on stage grouping and guidelines for diagnosis and pathology 
can be found in (23,24). 
1.2.1 External Beam Radiation Therapy 
External beam radiation therapy (EBRT) with curative intent is a main component in the 
current standard of care as primary or adjuvant treatment for early stage NSCLC and 
unresectable locally advanced NSCLC (23,25).  In addition, radiation therapy is used for 
palliative purposes for alleviating bronchial obstruction or to relieve symptoms such as 
pain, cough, or bleeding (8,23,26). 
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In EBRT, high-energy particles or waves such as x-rays, protons, gamma rays, or 
electron beams are planned to target the tumor cells and damage their DNA. Radiation-
induced damage to the DNA kills malignant cells or impairs their proliferation (8). 
Table 1-1 Summary of lung cancer staging guideline. Adapted from (99). 
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The amount of energy per unit mass that is deposited (or planned to be delivered) is 
measured as “dose” of radiation in Gray (Gy) (27). Radiation therapy generally ranges 
from static beams to multiple rotating beams all exploiting the concept of superposition 
to deposit the prescribed doses in the tumor volume while sparing surrounding normal 
tissue within the human body. The primary goal of radiotherapy is to maximize tumor 
control probability (TCP) while minimizing normal tissue complication probability 
(NTCP) (28). Therefore, the mitigation of high dose to organs at risk (OARs) and healthy 
tissue is crucial to the success of radiotherapy and avoiding negative radiation-related 
side effects. A treatment planning system is used for radiotherapy treatment planning, 
optimization and 3-dimensional dose calculation (29). For radiotherapy planning, a total 
prescribed dose is typically broken down into multiple treatment sessions or treatment 
fractions. Modern radiotherapy employs the use of 4-dimensional computed tomography 
(4DCT) imaging of the patient's body to target the tumor volume and guide the high-
energy radiation beams (29). Within the CT dataset, a physician segments the gross 
tumor volume (GTV), based on his or her own clinical experiences, as well as clinical 
guidelines on disease specific characteristics such as pattern specific progression and 
staging. Two additional margins are added on top of the GTV to account for different 
types of uncertainty in radiation delivery. The first supplementary margin is added to 
create the clinical target volume (CTV), which accounts for uncertainty related to 
microscopic spread of disease that is not visible to the physician in the CT dataset. A 
second margin is subsequently added on top of the CTV to account for uncertainties that 
arise from both inter- and intra-fractional motion, resulting in the internal target volume 
(ITV). The planning target volume (PTV) encompasses the ITV and is larger by margins 
to account for set-up variations, geometric uncertainties, and machine tolerances (29, 33). 
Subsequently, OARs and critical structures are also segmented. OAR segmentations are 
necessary, as they serve as dose limiting structures during treatment plan optimization. 
They need to be spared for successful treatment with minimal toxicities to ensure suitable 
long-term quality of life for patients.  
The radiation dose distribution and hence TCP and NTCP depend on the radiation 
therapy technology used. Modern radiation therapy techniques such as stereotactic body 
radiation therapy (SBRT) have been developed to provide better control over dose 
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distribution, compared to conventional techniques such as three-dimensional conformal 
radiation therapy (3D-CRT) (30). 3D-CRT uses multiple co-planar fields to maximize 
tumor dose coverage and minimize normal tissue exposure. In 3D-CRT, the prescribed 
dose is usually delivered over the course of four to eight weeks, in 20 to 40 daily 
fractions. The basic idea of CRT is based on tailoring the apertures of the beam to the 
shape of the PTV in 3D, while masking nearby OARs (Error! Reference source not 
found.) (31). A more complex beam configuration might be required when the PTV is 
close to an OAR, and to achieve an acceptable dose distribution a higher number of 
beams are often used. However, conventional 3D-CRT may fail in cases of concave-
shaped target volumes and moving targets. In addition, in 3D-CRT, beam margins by 
which the tumor is expanded to account for tumor and organ motion, and the planning 
and setup inaccuracies are large (on the order of centimeters) (31).  
SBRT refers to an emerging radiotherapy procedure that has been reported to be highly 
effective in controlling early stage primary and oligometastatic cancers at locations 
throughout the abdominopelvic and thoracic cavities, and at spinal and paraspinal sites. In 
SBRT, the PTV contains a much smaller margin together with the target tumor, 
compared to when 3D-CRT is used. The major feature that separates SBRT from 
conventional radiation treatment is the possibility of delivering large doses in a few 
Figure 1-5. Schematic of the 3D conformal radiation therapy. 
Reproduced with permission (31). Copyright 2008, SNMMI.  
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fractions, which results in a high biologically effective dose (32,33). Conformation of the 
ablative dose to the target shape and rapid decrease in the dose outside the target is 
critical for minimizing the normal tissue toxicity and hence the safe delivery of the high 
dose. Therefore, effective use of SBRT requires a high level of confidence in the 
accuracy of the radiation delivery process. To achieve this accuracy, SBRT is 
characterized by target localization using imaging (e.g. 4DCT, MR), patient 
immobilization, sophisticated planning software, accurate treatment delivery 
technologies, and the ability to produce a steep dose gradient outside the target volume 
(33). In addition to these major features, there are other characteristics that distinguish 
SBRT from conventional radiation therapy (30) (Table 1-2). These include a general 
increase in the number of beams used for treatment, the frequent use of noncoplanar 
beam arrangements, and the use of inhomogeneous dose distributions techniques such as 
Table 1-2 Comparison of some characteristics of 3D-CRT and SBRT. Reproduced with 
permission (30). Copyright 2010, John Wiley and Sons. 
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intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy 
(VMAT) (30). IMRT utilizes forward or inverse radiation treatment planning to 
determine and deliver the necessary dose distribution through the use of multileaf 
collimators (Figure 1-6) (34). VMAT is a more advanced type of IMRT that decreases 
the delivery time by applying the dose in a single gantry arc and improves the dose 
conformality by using the full 360° range of gantry rotation (35).  
Accurate delivery of ablative radiation is challenging for extracranial lesions due to inter- 
and intra-fraction tumor and organs motion. Respiration-induced motions of the target 
and OAR renders the treatment delivery even more challenging for lung tumors (33). 
This motion can cause inaccuracies and uncertainties in radiation therapy, and artifacts in 
imaging of the thoracic tumors resulting in higher probabilities of treatment 
complications such as irradiating normal tissue (increase in NTCP) and undesirable dose 
distribution in target tumor (decline in TCP) (36,37). Therefore, motion compensation 
methods are highly essential for safe delivery of large fractions of radiation therapy. 
Section 1.3 describes current motion management methods as well as an overview of the 
real-time tumor tracking workflow previously proposed by our group.  
Current methods of radiation therapy treatment planning assume a homogeneous 
Figure 1-6. 3D CRT vs. IMRT. (a) in 3D CRT, dose conformality is limited to the 
open/close aperture configuration, while (b) IMRT, offers higher dose conformality 
resulting in smaller margins and higher potential for less toxicity to OAR. Reproduced 
with permission (100). Copyright 2006, Springer-Verlag Berlin Heidelberg.  
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distribution of lung function (38). However, as mentioned in section 1.1.2, pulmonary 
abnormalities such as COPD and asthma commonly coexist with lung cancer, leading to 
pulmonary function heterogeneity. To limit high radiation dose delivery to healthy tissue, 
functional avoidance treatment planning has been proposed (5,38,39). This method 
preferentially spares the functional lung tissue from radiation dose during treatment 
planning. Section 1.4 provides more information on functional avoidance planning, the 
current functional imaging methods and an overview of our proposed ventilation imaging 
technique that can be used for functional avoidance planning.   
1.3 «Motion Management Methods» 
Accounting for inter- and intra-fraction motions of the target and OAR are critical for the 
safe delivery of radiation dose. The location of the target and OAR may be different from 
their location at the radiation treatment planning and simulation. Accurate positioning of 
the target lesion in the isocenter of the radiation therapy machine requires that the body 
geometry during the treatment session is almost identical to the body geometry during 
treatment planning simulation. In addition, it is required to suppress or, if possible, 
eliminate the voluntary motion of the body during treatment (33). Henrik Blomgren and 
Ingmar Lax designed a body frame to minimize the inter-fraction motion. This body 
frame allows comfortable repositioning of the patient’s body relative to the frame. The 
frame is equipped with fiducial markers that determine the coordinates system relative to 
the frame geometry, and hence enable an accurate localization of the body relative to the 
simulator and the treatment accelerator (40). Vacuum systems have also been developed 
for enforcing patient immobilization and are used in some centers (33). Although the 
body frames or the vacuum systems largely resolves the inter-fraction motion issues, the 
intra-fraction motion and deformation of the lungs and the tumor caused by respiration 
can significantly increase the uncertainties in radiation treatment and compromise its 
accuracy and effectiveness. To account for respiratory motion, several motion 
compensation methods have been proposed.  
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1.3.1 Motion Encompassing 
In motion encompassing treatment planning, the PTV includes the target volume at end-
exhalation phase, or GTV (obtained from treatment planning 4DCT), along with a large 
margin that encompasses the entire path of the tumor motion/deformation (Figure 1-7) 
(41). In this method, the PTV which is irradiated with high dose radiation is larger than 
the GTV and may include a significant volume of the healthy lung tissue (42). This may 
lead to higher chances of radiation-induced toxicities and higher NTCP. The motion 
encompassing method can only be used when the amplitude of the target motion is less 
than 5mm, because otherwise the potential damage extent to the healthy tissue is deemed 
unacceptable (3). Several studies have investigated the amplitude of the motion of the 
tumor in different directions (43–46), and a few others studied the range of motion during 
diaphragm contraction (47,48). According to Table 1-3, on average the range of lung 
tumor motion/deformation is larger than 5 mm (3). Therefore, other motion compensation 
methods with better accuracy for sparing of normal tissue are required.  
1.3.2 Gated Methods 
Gated radiation therapy methods for lung cancer are developed based on the assumption 
that during the respiratory cycle there is a particular span of time where the amplitude of 
the respiratory motion is small (Figure 1-8). To decrease the treatment field margins (for 
PTV), in gated procedures, the radiation beam is only applied during the portion of the 
Figure 1-7. Motion encompassing. PTV includes the entire path of tumor’s motion from 
expiration to inspiration, along with extra safety margins. 
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breathing cycle with the smallest target motion (the gating phase). The gating phase of 
the breathing cycle has to be identified and verified positionally for each patient and the 
beam has to be switched on and off accordingly during the treatment session (49). Real-
time information on the breathing cycle is required for this method to enable 
synchronizing the on and off turning of the beam. Breathing monitoring devices for 
respiratory gating most often rely on surrogates for the actual motion of the target, such 
as an external optical skin marker or a pressure sensor. 
The variability and irregularity of breathing patterns results in a lack of predictability of 
breathing motion. Therefore, as shown by Korreman et al. (50), image guidance is of 
utmost importance for respiratory gated treatments. The correspondence between the 
breathing motion recorded from the external surrogate and the breathing motion of the 
target can change, not only from fraction to fraction but also within each treatment 
fraction. Therefore, when external surrogates are used for motion monitoring, the 
correspondence between the motion of the surrogate and target motion needs to be 
Table 1-3 Respiratory-induced motion of the lung tumor and diaphragm in different 
directions. Reproduced with permission (3). Copyright 2006, John Wiley and Sons.  
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updated and verified regularly. Otherwise, the target may not receive the effective dose 
while the normal tissue receives toxic radiation (49).  
Several imaging techniques can be used during radiation therapy and for treatment 
planning of gated procedures. During treatment, radiographic and fluoroscopic kV 
imaging are now standard for new machines. Imaging equipment can either be mounted 
on the linear accelerator gantry, which is mostly orthogonal to the treatment beam, or can 
be independently mounted on the ceiling or floor of the treatment room, orthogonally. 
Two orthogonal imaging setups can be combined to provide semi-3D information. 
Imaging units mounted on the gantry can also be used for cone-beam CT imaging. 
Because the acquisition time of cone-beam CT (CBCT) is long compared to the breathing 
cycle, the target position image may appear blurred in the image. 4D CBCT has also been 
developed that acquires phase-resolved CBCT(49,51). 
Respiratory gated methods do not completely abolish the need for margins when 
assigning the PTV. Breathing motion patterns are not stable (especially among lung 
Figure 1-8. Gated Radiation therapy. The motion of the tumor is smallest at certain 
windows of time (gates) during respiration. The radiation is applied only during these 
gates. Reproduced with permission (49). Copyright 2015, British Journal of Radiology. 
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cancer patients), and hence not completely reproducible in the spatial domain. If not 
accounted for, irregularities in the breathing cycle can render the gated procedures 
unreliable. Therefore, treatment margins are required to account for the uncertainties 
caused by the residual motion. The uncertainties (and hence the margins) can be reduced 
by combining the gated procedures with motion limiting methods. This increases the 
chance of delivering the dose to the target as prescribed by the treatment plan (33,52). 
Although the modern gated methods can improve the confidence in the accuracy required 
for an effective SBRT, they come with shortcomings. The gated sessions inevitably take 
longer and this increase in the treatment time can cause inconvenience for the patient that 
can lead to body dislocation relative to the treatment frame, and hence a decrease in the 
accuracy of treatment delivery. In addition, longer treatment times can have potential 
radiobiological consequences caused by the decreased average dose ratio during 
treatment (33).  
1.3.3 Motion Limiting Methods 
Motion limiting methods aim at controlling the respiratory motion amplitude by limiting 
the breathing volume. Abdominal compression devices can be used along with the body 
frames during SBRT to decrease the respiration-induced tumor motion and hence the 
treatment margins. These devices, however, can cause discomfort or even anxiety for 
some patients, that may lead to an increased variability in tumor motion. In addition, the 
abdominal compression does not eliminate the tumor motion, and this method is not 
practical for obese patients (53).  
Breath-hold techniques attempt to eliminate respiratory motion either voluntarily or by 
using occlusion valves. The holding of the breath allows for a temporary immobilization 
of the target tumor when the radiation is planned to be applied. Figure 1-9 illustrates 
typical respiratory motion amplitude variation as a function of time where this motion 
limiting method is utilized. Patients must be trained on the required breathing maneuver 
for both treatment planning CT and radiation therapy session. The patients are required to 
hold their breath for 10-20 seconds in each iteration. While relatively effective for target 
immobilization, breath-hold techniques are not very commonly used because most lung 
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cancer patients have poor pulmonary function and cannot undergo breath-hold procedures 
(54).  
 
1.3.4 Real-time Tracking Methods 
Real-time tumor tracking has been proposed as an alternative motion management 
technique in which the radiation beam dynamically follows the target throughout the 
treatment. A real-time tumor tracking system ideally follows the motion and deformation 
of the tumor during the entire respiratory cycle, allowing a continuous radiation 
treatment. There are certain requirements that need to be met for achieving a radiation 
therapy system with real-time tracking as the motion management technique, including 
(but not limited to): 1) an accurate estimation of the tumor location and geometry in real-
time, 2) in advance prediction of the tumor motion/deformation to account for the delays, 
3) an adaptive radiation dose planning system, and 4) a beam alignment system (55,56).  
Figure 1-9. Breath-hold methods. The respiratory motion amplitude decreases during the 
breath-hold span. The radiation is applied during this span to reduce uncertainties caused 
by tumor motion. Reproduced with permission (49). Copyright 2015, British Journal of 
Radiology. 
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Although imaging techniques are available for use during treatment, for high precision 
tumor tracking purposes in real-time, markers implanted in the tumor have been proposed 
to increase visibility. This technique has been developed by SynchronyTM Respiratory 
Tracking system (Accuray, Sunnyvale, CA). In this system, gold fiducials are implanted 
inside the tumor and their motion is monitored by a pair of orthogonal X-ray images. In 
addition to the image data, a correlation model used as a location predictor is developed 
with an optical monitoring system tracking light emitting markers placed on a vest worn 
by the patient. The correlation model compensates for the time delay between data 
acquisition and the repositioning of the accelerator. The accelerator is robotically 
controlled and allows for non-isocentric beam delivery within a solid angle of over 2π. 
The position of the external markers is continuously monitored while the X-ray imaging 
of the internal fiducials is performed every 3–5 beams (a flexible parameter). Apart from 
accuracy, another major advantage of this method is that the patient breathes freely 
during the treatment (57). Tracking the tumor without the need for simultaneous imaging 
by implantation of radiofrequency beacons has also been reported, e.g. using the Calypso 
system (58). Similar to other tracking systems that are based on implanted fiducials, with 
these tracking systems, the translational movement of the tumor can be captured and 
compensated for, while the rotation and deformation is not accounted for. As a result, 
treatment margins of up to 5 mm may be required depending on the case (33,59). Recent 
studies indicate that, during respiration, the size of the target tumor can vary by up to 62% 
(60). As such, an effective tumor tracking method should be able to estimate the tumor 
deformations as well as translation and deformation. In addition, marker implantation is an 
invasive procedure and can be associated with side effects. Risks of pneumothorax for 
percutaneous implantation is reported to be as high as 30%, with 10% of the cases 
requiring intervention (61,62). To avoid marker implantation, an improved tracking 
method, X-sight Lung (Accuracy, Sunnyvale, CA) has been developed that can 
dynamically track tumor motion based on the radiograph images for certain lung cases (in 
some centers, about 30% of patients). Concurrent X-ray imaging and radiation therapy, 
however, has raised some concerns about the additional imaging dose (33).  
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1.3.5 Tumor Tracking Workflow  
A real-time tumor tracking workflow has been previously proposed by our group (63). 
This tumor tracking scheme will not require simultaneous imaging during the treatment, 
can also estimate motion and deformation of the tumor, and will only use external 
markers. In addition, this method is potentially less sensitive to irregularities in the 
breathing pattern. An overview of this method is shown in Figure 1-10.  During the pre-
treatment step, an optical tracking system is incorporated into the treatment planning 
4DCT acquisition. A tumor motion and deformation estimation algorithm based on an 
accurate patient-specific biomechanical model of the lung is developed using the 
treatment planning 4DCT data. The chest surface motion data is acquired simultaneously 
with the treatment planning 4DCT using optical tracking of the external markers. The 
chest surface motion data can be correlated to the tumor motion/deformation obtained 
from the finite element (FE) model.  
The information from chest motion data is considered as input parameters while the 
parameters of the biomechanical model (in a compact form) will be used as the output for 
training a predictive model (e.g. an artificial neural network). After training the predictive 
model, a relationship is established between the chest surface motion data and the 
parameters of the FE model that directly provides the tumor motion/deformation. For 
more detailed information on the proposed real-time tracking workflow, see (63).  
The accuracy of the biomechanical model used in this method is critical to the successful 
development of the real-time tracking. The second chapter of this thesis explains 
development of an accurate biomechanical model for tumor motion and deformation 
estimation.  
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1.3.6 Biomechanical model-based tumor motion/deformation 
estimation 
Lung motion/deformation estimation using information from 4DCT scans has been 
widely studied for different applications including tumor motion tracking. Although 
intensity-based deformable image registration (DIR) methods have been employed to find 
the motion/deformation fields of the lungs and the tumor for dose calculation and 
treatment planning purposes, their application in real-time tumor tracking is limited to a 
few studies (56,64–66). In addition, intensity-based DIR methods are solely based on 
Figure 1-10. The biomechanics-based real-time tumor tracking workflow.  
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4DCT image data, and they do not take into account the physical properties or 
physiological mechanisms involved in breathing. Therefore, they are prone to errors 
associated with non-uniqueness of the resulting displacement field, and registration errors 
in areas with low image contrast. Handling the sliding motion of the lungs can also be 
challenging for motion estimation using intensity-based DIR methods. Biomechanical 
models can be adapted to address these limitations; they are widely used alone or in 
combination with intensity-based methods. In contrast to intensity-based DIR, 
biomechanics-based computational models encompass certain aspects of breathing 
dynamics rendering this approach more robust and realistic. Patient-specific lung 
biomechanical models that use the thoracic image data to extract the lung’s geometry and 
boundary conditions have previously been proposed. Several studies investigated the 
effects of model parameters, including tissue mechanical properties (67–69), and 
boundary conditions (70) on modeling accuracy. Recently, hybrid hierarchical 
approaches have been proposed, in which finite element (FE)-based models are used in 
conjunction with intensity-based DIR methods to predict deformation field of the lung in 
a respiratory cycle, and to register lung CT image pairs. For example, Han L. et al., 
proposed a hybrid biomechanical model-based DIR for lung peak CT pairs, and showed 
that the resulting deformation field can more realistically describe the underlying 
physiology to improve the registration accuracy compared to the intensity-based DIR 
algorithm (71). 
In chapter 2, we describe a heterogeneous biomechanical model of the lung for accurate 
estimation of the tumor motion and deformation. This biomechanical model takes into 
account the heterogeneity in the mechanical behavior of the lung tissue that is caused by 
co-existing COPD phenotypes. 
1.4 «Functional Avoidance Treatment Planning» 
As mentioned in section 1.2.1, EBRT is the main method of treatment for many lung 
cancer patients. However, EBRT is associated with increased risk of radiation-induced 
toxicities such as radiation pneumonitis or radiation fibrosis. Radiation pneumonitis with 
clinical symptoms occurs in 30-40% of lung cancer patients after receiving concurrent 
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chemoradiotherapy and can have an adverse impact on their quality of life. This adverse 
effect sometimes results in oxygen dependence and is fatal in severe cases (25).  
Current radiation therapy treatment planning methods used in many centers assume that 
the lung function is homogeneous, and do not take into account regional differences in 
pulmonary function. Therefore, the goal in treatment planning is to minimize the 
radiation dose to the total lung volume. However, as mentioned in section 1.1.3, many 
lung cancer patients suffer from comorbidities such as COPD, which affect the regional 
distribution of lung function. Functional avoidance-based treatment planning has 
emerged as a new treatment planning approach, aiming to overcome the limitations 
caused by the assumption of homogeneous function (25). Ideally, the radiation therapy 
dose should be planned based on minimizing the radiation dose to the well-functioning 
volumes of the lung while favoring radiation deposition in the lower functioning 
volumes.  
Regional information on lung function is a requirement for functional avoidance 
planning. Over the last decade, functional imaging maps have been investigated for lung 
cancer treatment planning. Positron emission tomography (PET) and single-photon 
emission computed tomography (SPECT) scans can be used to obtain functional 
information in terms of ventilation and perfusion (72,73). Some researchers have used 
PET or SPECT for functional avoidance planning and assessment of the radiation 
treatment response (39,74). Nuclear medicine imaging approaches have a relatively low 
resolution compared to other imaging modalities. Hyperpolarized 3He MR imaging can 
provide information on regional ventilation, and hyperpolarized 129Xe MRI can be used 
to obtain information on ventilation, perfusion, or gas exchange (75–77). Although 
hyperpolarized gas MRI has enough temporal resolution for ventilation imaging, it is 
relatively costly and require tracer gases and additional equipment. Xe-enhanced CT can 
be used to provide direct assessment of ventilation distribution (78). Xe (Xenon) gas is 
also relatively costly and requires associated hardware to control the delivery. In addition, 
this method is limited to axial coverage of about 12-15cm, which may not be sufficient 
for thoracic imaging. Using any of the abovementioned modalities for a functional 
imaging would also require an extra step of multi-modal image registration with the 
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radiation therapy treatment planning CT scans that may introduce errors in lung function 
mapping. 
4DCT-based ventilation imaging (CTVI) has recently emerged as a cost-effective and 
accessible alternative for functional avoidance planning. The CTVI can be considered as 
“free information” for functional avoidance planning because 4DCT scans are part of the 
routine care for lung cancer patients in many centers. Therefore, acquiring CTVI only 
involves additional computational steps, e.g. image processing and analysis.  
CTVI-based functional avoidance planning is currently investigated in a number of 
clinical trials (79–81). Attempts have been made to validate different CTVI techniques 
against a wide range of clinical and experimental modalities for ventilation imaging, 
including 99mTc-labelled diethylenetriamine pentaacetate (DTPA) V-SPECT (82), 68Ga 
(Galligas) PET (83), 3He MRI (84), 129Xe MRI (85), 81m-Kr (86) and Technegas V-
SPECT (87). 
1.5 «4DCT Ventilation Imaging Methods» 
Different approaches have been proposed for CTVI where most of them rely on a 
deformable image registration (DIR) algorithm, combined with a ventilation metric. 
Some groups used off-the-shelf DIR algorithms while others utilized in-house DIR 
methods. The accuracy of the DIR algorithm is critical to the accuracy of the generated 
CTVI, however, there has not been a consensus on which algorithm should be used. For a 
comprehensive review on different DIR algorithms that have been used for CTVI, see 
(88). As for the ventilation metric, current CTVI methods are generally classified as 
either Hounsfield units (HU)-based or Jacobian-based algorithms. A few studies have 
investigated the combination of the two (88). In the HU-based approaches, the change in 
the amount of air in the voxels is considered the surrogate for ventilation. Simon et al. 
proposed a relationship between manually registered CT values in Hounsfield units (HU), 
HUinhale and HUexhale, and the regional volume change. They assume that the fraction of 
air in a CT region is given by:  
 
𝐹𝑎𝑖𝑟 = −
𝐻𝑈
1000
 , (1) 
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where 𝐻𝑈 is the image intensity of each voxel (89). The fractional change in air content 
within a specified volume is then given by:  
 ∆𝑉
𝑉𝑒𝑥
= 
(𝐹2 − 𝐹1)
𝐹1(1 − 𝐹2)
 , (2) 
where ∆𝑉 is the local volume change due to inspiration, 𝑉𝑒𝑥 is the volume of air within 
the exhale CT volume of interest, 𝐹1 is the fraction of air in the exhale CT volume of 
interest and 𝐹2 is the corresponding fraction of air in the inhale CT volume of interest. If 
we consider the initial exhale volume as a discretized CT voxel, and assume that a three-
dimensional vector transformation exists to map the set of inhale lung CT voxels into the 
exhale image domain, one can derive the following expression for local ventilation in 
terms of registered CT numbers corresponding to inhalation and exhalation breathing 
states: 
 ∆𝑉
𝑉𝑒𝑥
= 1000 
(?̅?𝑖𝑛ℎ𝑎𝑙𝑒
𝑉𝑂𝐼 − 𝐻𝑈𝑒𝑥ℎ𝑎𝑙𝑒)
𝐻𝑈𝑒𝑥ℎ𝑎𝑙𝑒(1000 + ?̅?𝑖𝑛ℎ𝑎𝑙𝑒
𝑉𝑂𝐼 )
 , (3) 
where ?̅?𝑖𝑛ℎ𝑎𝑙𝑒
𝑉𝑂𝐼  is the average of all the HU corresponding to the set of inhale voxels that 
map into the exhale voxel under consideration (90). 
Concerns due to physiological violation of the ventilation model given by this equation, 
as well as uncertainty resulting from image noise, data acquisition and image 
reconstruction artifacts have led others to investigate alternative methods for quantifying 
lung function that are independent of the image CT values. Regional volume can be 
measured using the Jacobian of the DIR deformation field, Φ (?⃗?), alone (91,92). The 
Jacobian is defined as the determinant:  
𝐽Φ(?⃗?) = det
[
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which calculates the differential expansion (or contraction) at position ?⃗? in the image. 
Consider 𝐵?⃗? as a small box around ?⃗? in the exhale image such that Φ (𝐵?⃗?) is the 
corresponding deformed box in the inhale image. The Jacobian determinant of the 
deformation Φ (?⃗?) at ?⃗? is  
 
𝐽Φ(?⃗?) =  
𝑣𝑜𝑙(Φ(𝐵?⃗?))
𝑣𝑜𝑙(𝐵?⃗?)
 , (4) 
where 𝑣𝑜𝑙(𝐵?⃗?) is the volume of the small box centered at ?⃗? and 𝑣𝑜𝑙(Φ (𝐵?⃗?)) is the 
volume of the corresponding deformed box. Note that the fractional change in volume 
equals the Jacobian determinant of the deformation field at that location. The Jacobian 
calculation is independent of the CT values and only depends on the DIR transformation 
Φ. 
In Chapter 3 we describe our proposed CTVI method that combines a biomechanical 
model-based DIR with an accurate air segmentation algorithm. The proposed CTVI 
method has qualitatively and quantitatively been compared against the patients’ 
hyperpolarized 3He MR.  
Next sections (1.6 to 1.9) present the theoretical background required for developing the 
proposed methods for tumor motion/deformation estimation using the lung 
biomechanical model, and the proposed 4DCT ventilation imaging technique. 
1.6 «Image Segmentation» 
 Image segmentation is defined as partitioning a two-dimensional (2D) or 3D image into 
multiple classes. Each class is called a segment and includes voxels that share a property, 
hence belong to that class. Image segmentation has various applications in the field of 
computer vision, including object recognition, image database look-up, or image 
compression. In medical image analysis, image segmentation is usually used to outline an 
object or organ of interest manually or automatically. For example, before a tumor is 
analyzed in a CT image, it must be detected and isolated from the rest of the image. This 
task is performed using image segmentation. Segmentation of medical images also allows 
comparison of object/organ of interest between different datasets or modalities and 
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monitoring changes in the object/organ of interest (e.g. in treatment response 
assessment). It also enables extracting useful quantitative information from images.  
1.6.1 Region Growing Algorithm 
Region growing is an iterative algorithm used for image segmentation that has a similar 
concept to clustering algorithms such as k-means clustering (93). Initially, one or more 
points (seeds) are assigned in each of the segments either manually or automatically. In 
each iteration, the pixels around a seed point are examined and determined whether each 
pixel belongs to the segmentation class (segment). If yes, this pixel is added to the seeds 
of that segment. The choice of criterion by which a pixel is allocated to a segment has an 
impact on the final result of segmentation. For example, one criterion is to choose a pixel 
as a member if its grayscale value is close to the average grayscale values of the region. 
The definition of “closeness” can also influence the results. In many applications, 
closeness is defined as a distance smaller than 1-3 times the standard deviation of the 
pixels’ intensity values in the region. This process continues until all the pixels in the 
image are allocated to one and only one of the growing regions (93).  
1.7 «Image Registration»  
Image registration is defined as the process of aligning two or more images taken from 
the same scene under different conditions, e.g. images taken from a landscape from 
slightly different angles or viewpoints, CT images taken from a tumor before and after 
the course of treatment, the MR and the CT taken from a patient’s brain, etc. Image 
registration involves designating one of the images as the fixed (reference) image, while 
the other image is assigned as the moving image. The geometric transformations and/or 
local displacement fields are applied to the moving image so that it aligns with the fixed 
image (94,95). Usually, image registration is performed as a preliminary step to prepare 
the images for another image processing algorithm. For example, the CT images acquired 
from the patient’s lung at end-exhalation phase is registered to the image of the same 
patient’s lung at end-inhalation phase to extract and quantify certain pathophysiological 
conditions (96).  
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Based on the process that was involved between the acquisition of the two images, a 
combination of different transformations might be required to register the images. The 
transformation can be rigid (translation and rotation), affine (rigid + scaling and 
shearing), or deformable registration (2-3 degrees of freedom for each pixel). Figure 1-11 
shows the flowchart of a registration algorithm. There are essential components to any 
image registration algorithm (97). A metric is used to compare the closeness of the 
moving and the fixed image after a transformation. Proper choice of the metric can have a 
significant impact on the performance and the results of the registration. Commonly used 
metrics include: mean squared errors, normalized cross correlation, and normalized 
mutual information. The latter is the best choice for multi-modality image registration 
(e.g. between MR and CT).  An optimizer is required to find the minimum (or maximum, 
based on the choice of metric) of the metric that will result in the best alignment of the 
two images. Choosing the proper optimizer and its parameters (e.g. step size, relaxation 
factor, etc.) can be very important for performance of the registration algorithm. The 
interpolators are used for calculating the pixels grayscale values after transformation. 
When the image is transformed, the pixels may land on non-integer locations (i.e. not on 
the fixed image grid). Therefore, an interpolator is required to reconstruct the transformed 
image.  
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1.8 «Theory of Elasticity» 
Elasticity is a property of solid materials to regain their original shape after an external 
force is removed. Theory of elasticity describes the mechanical behavior (i.e. deformation 
and failure) of the elastic materials under the application of external force. Continuum 
mechanics deals with the mechanical behavior of materials that can be considered as a 
continuous mass rather than discrete parts or particles and is therefore based on the 
continuum hypothesis: “matter is continuously distributed, and regardless of how small 
volume elements the matter is subdivided into, every element will contain matter. The 
matter may have a finite number of discontinuous surfaces, for instance fracture surfaces 
or yield surfaces, but material curves that do not intersect such surfaces, retain their 
continuity during the motion and deformation of the matter” (98). 
Virtual Image 
Figure 1-11. Flow chart of a general registration algorithm. A metric is used to compare 
the fixed image with the moving image after each time the moving transform is updated. 
The optimization stops when the metric or changes in the metric are smaller than a 
predefined limit. The virtual image is reconstructed after the optimization is completed. 
Adapted from The ITK Software Guide Book 2 Fourth Edition, by Johnson H.J., 
McCormick M.M., Ibáñez L., and the Insight Software Consortium.  
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A continuum is characterized by a mass 𝑑𝑚, contained in an elementary volume 𝑑𝜏 =
 
𝑑𝑚
𝜌
. 𝜌 is referred to as the mass density. A material continuum occupying a volume 𝑣 
with a surface 𝑜 (initial state), will reach a new equilibrium state with the volume 𝑉 and 
the surface 𝑂 (final state). The position of the material particle is defined in a Cartesian 
coordinate as (the summation over the dummy index 𝑠 is omitted for brevity):  
 𝑿 =  𝑎1𝒊1 + 𝑎2𝒊2 + 𝑎3𝒊3 = 𝑎𝑠𝒊𝑠, (5) 
where 𝒊𝑠 is the base unit vector of the coordinate axes. Similarly, the final state of the 
material particle is:  
 𝒙 =  𝑥1𝒊1 + 𝑥2𝒊2 + 𝑥3𝒊3 = 𝑥𝑠𝒊𝑠. (6) 
The displacement vector moving the material particle from the initial state to the final 
state is: 
 𝒖 (𝑿, 𝑡) =  𝒙(𝑿, 𝑡) − 𝑿,   (7) 
which can be written as:  
 𝒖 (𝑿, 𝑡) = 𝑢1𝒊1 + 𝑢2𝒊2 + 𝑢3𝒊3 = 𝑢𝑠𝒊𝑠, (8) 
and therefore:  
 𝑢𝑠 = 𝑥𝑠 − 𝑎𝑠. (9) 
See Figure 1-12.  
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Figure 1-12. A particle in the elastic geometry at its initial state (𝑿), displaced by 
𝒖 (𝑿, 𝒕) to its final state (𝒙(𝑿, 𝒕)). 
The displacements, i.e. the projections of the displacement vector (i.e. 𝑢𝑠), are functions 
of the initial position of the material particle (𝑎𝑠), and hence the dependence of  𝒖 on 𝑿 in 
Eq. 7. For the equation to have a unique solution, the Jacobian (Eq. 10) must not vanish 
in the closed domain 𝑣 +  𝑜. 
 
𝐽 (𝑎1, 𝑎2¸𝑎3) =  | 
𝜕𝑥𝑠
𝜕𝑎𝑘
 | =  | 𝛿𝑠𝑘 + 
𝜕𝑢𝑠
𝜕𝑎𝑘
 | =  
|
|
1 + 
𝜕𝑢1
𝜕𝑎1
𝜕𝑢1
𝜕𝑎2
𝜕𝑢1
𝜕𝑎3
𝜕𝑢2
𝜕𝑎1
1 + 
𝜕𝑢2
𝜕𝑎2
𝜕𝑢2
𝜕𝑎3
𝜕𝑢3
𝜕𝑎1
𝜕𝑢3
𝜕𝑎2
1 + 
𝜕𝑢3
𝜕𝑎3
 
|
|
.  (10) 
The Jacobian (𝐽) is the deformation gradient tensor, also denoted by 𝑭. 𝑭 can be re-
written as:  
 𝑭 = 𝑰 + ∇𝒖,  (11) 
where ∇𝒖 is the displacement gradient, and 𝑰 is the identity tensor. The following 
equation is derived from Eq. 7 and Eq. 11 using differential calculus principles:  
 𝑑𝒙 = 𝑑𝑿 + (∇𝒖)𝑑𝑿 = 𝑭𝑑𝑿,  (12) 
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where 𝑑𝒙 and 𝑑𝑿 are the distance between two infinitesimally close points in the final 
and initial volumes. Therefore, the square of the linear elements (i.e. the inner product of 
the distance 𝑑𝒙 with itself) in the final volumes becomes:  
 𝑑𝑠2 =  𝑑𝒙. 𝑑𝒙 = 𝑑𝑿𝑭𝑻𝑭𝑑𝑿.  (13) 
We substitute 𝑪 =  𝑭𝑻𝑭, and obtain 
 𝑑𝑠2 = 𝑑𝑿𝑪𝑑𝑿,  (14) 
where 𝑪 is called the right Cauchy-Green deformation tensor. In distance-preserving 
transformations (e.g. rigid body motion), 𝑑𝑠2 = 𝑑𝑿. 𝑑𝑿 and therefore 𝑪 = 𝐼.  Substituting 
Eq. 11 in Eq. 13 we can find the relationship between the right Cauchy-Green 
deformation tensor and the displacement gradient: 
 𝑪 = (𝑰 +  𝛻𝒖)𝑇(𝑰 +  𝛻𝒖) = 𝑰 +  𝛻𝒖 + (𝛻𝒖)𝑻 + (𝛻𝒖)𝑻(𝛻𝒖). (15) 
𝑬 is the Green-Lagrange strain tensor and is calculated from the displacement as: 
 
𝑬 = 
1
2
[𝛻𝒖 + (𝛻𝒖)𝑻 + (𝛻𝒖)𝑻(𝛻𝒖)]. (16) 
Therefore: 
 𝑪 = 𝑰 + 2𝑬.  (17) 
To obtain the Green-Lagrange strain tensor from the deformation gradient tensor F, we 
can use 𝑪 =  𝑭𝑻𝑭 and Eq. 17: 
 
𝐸 =  
1
2
 [𝑭𝑻𝑭 − 𝑰]. (18) 
The advantage of using this formulation to calculate the Green-Lagrange strain tensor is 
that it uses the reference body configuration instead of the deformed (final) state.  
To obtain the strain values in all directions at each point from displacements, we start 
with the simple case and assume that the displacements (and their partial derivatives) are 
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small. In this case, in Eq. 16 the higher order term (𝛻𝒖)𝑻(𝛻𝒖) becomes negligible, and 
we can simplify the strain tensor to the infinitesimal strain tensor:  
 
𝜺 =  
1
2
[𝛻𝒖 + (𝛻𝒖)𝑻]. (19) 
Now the strain values can be obtained from displacements in the Cartesian coordinate as:  
 
𝑖𝑗 =
1
2
(
𝜕𝑢𝑖
𝜕𝑿𝑗
+ 
𝜕𝑢𝑗
𝜕𝑿𝑖
). (20) 
This formulation can be used to calculate strains from displacement when the 
deformation of the elastic material under the external force is infinitesimal, and no 
intrinsically nonlinear elastic behavior is expected from the material. 
In cases where the material undergoes large deformations, we can no longer ignore the 
higher order terms in the calculation of the strain tensor. The strain components can 
therefore be calculated as:  
 
𝐸𝑖𝑗 = 
1
2
(
𝜕𝑢𝑖
𝜕𝑿𝑗
+ 
𝜕𝑢𝑗
𝜕𝑿𝑖
) + 
1
2
𝜕𝑢𝑚
𝜕𝑿𝑖
𝜕𝑢𝑚
𝜕𝑿𝑗
, 𝑚 = 1,2,3. (21) 
To formulate the mechanical behavior of the material under external forces, the 
relationship between the stress tensor and the strain tensor should be described. In this 
regard, the internal traction vector 𝒕 of a force 𝑭 that acts on a plane is defined as: 
 
𝒕 =  
𝑑𝑭
𝑑𝐴
 (22) 
where 𝑑𝐴 is a very small differential area on the plane where the force 𝑑𝑭 is applied. The 
vector 𝒕 can be expressed in terms of components of true (Cauchy) stress. For each 
component of 𝒕 normal to each face of the infinitesimal cube (𝒕𝑵𝟏 , 𝒕𝑵𝟐 , 𝒕𝑵𝟑) (Figure 1-13), 
the corresponding stress components are used:  
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{
𝒕𝑵𝟏 = 𝜎11𝑵𝟏 + 𝜎12𝑵𝟐 + 𝜎13𝑵𝟑
𝒕𝑵𝟐 = 𝜎21𝑵𝟏 + 𝜎22𝑵𝟐 + 𝜎23𝑵𝟑
 𝒕𝑵𝟑 = 𝜎31𝑵𝟏 + 𝜎32𝑵𝟐 + 𝜎33𝑵𝟑
, (23) 
Or in a compact form: 
 𝒕𝑵𝒊 = 𝜎𝑖𝑗𝑵𝑗 , 𝑖 ∈ {1,2,3} 𝑎𝑛𝑑 𝑗 ∈ {1,2,3}. (24) 
In these equations, 𝑵𝑗 is the unit vector normal to the corresponding face of the 
infinitesimal cube (Figure 1-13).  
 
Figure 1-13. The infinitesimal cube and the unit vectors normal to its surfaces, used for 
calculating internal traction.  
Having the relationship between the internal traction vector for each particle (cube as in 
Figure 1-13) and the components of the Cauchy stress, we can write the equilibrium of 
force for the cube, that is the infinitesimal volume of the continuum material. Newton’s 
second law must be satisfied for the infinitesimal cube, hence the following equation 
shows the equilibrium per unit volume of the cube: 
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 𝜕𝒕𝑁1
𝜕𝑥1
+ 
𝜕𝒕𝑁2
𝜕𝑥2
+
𝜕𝒕𝑁3
𝜕𝑥3
+  𝜌𝑩 =  𝜌𝒂,  (25) 
 
𝑜𝑟 ∶  
𝜕𝒕𝑁𝑗
𝜕𝑥𝑗
+  𝜌𝐵𝑗𝑁𝑗 =  𝜌𝑎𝑗𝑁𝑗 , 𝑗 𝜖 {1,2,3}, (26) 
Where B is the body force per unit mass through the continuum. We use the Cauchy 
stress representation of 𝒕𝑁𝑗, and we can write the equilibrium equation as follows:  
 𝜕𝜎𝑖𝑗
𝜕𝑥𝑗
+  𝜌𝐵𝑖 =  𝜌𝑎𝑖,   𝑖 𝜖 {1,2,3}  𝑎𝑛𝑑   𝑗 𝜖 {1,2,3}.  (27) 
The above equation in the tensor form is:  
 𝑑𝑖𝑣 𝝈 +  𝜌𝑩 =  𝜌𝒂. (28) 
The above equation is called the Cauchy’s equation of motion that describes the 
deformation of the continuum body.  
To find the mechanical behavior of an elastic material under external forces, we need 
information about the mechanical properties of the material, e.g. its stiffness and 
incompressibility that define its active deformation pattern due to specific loading 
conditions. Typically, the intrinsic mechanical behavior of the material is represented by 
a relationship between the generated stresses and the strains in the continuum body. This 
relationship is known as a constitutive law.  
1.8.1 Linear Elasticity 
 The constitutive law for linear elastic materials is given by the Hook’s law. Hook’s law 
defines the relationship between the components of Cauchy stress (𝜎𝑖𝑗), and the 
components of the strain tensor ( 𝑘𝑙) for continuum material particles as: 
 𝜎𝑖𝑗 = 𝐶𝑖𝑗𝑘𝑙 𝑘𝑙, (29) 
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where 𝐶 is known as the elasticity tensor and is of order 4. The elasticity tensor has 34 =
81 entries, however, 21 of which are enough to fully characterize the elastic behavior of 
the material. When the material is isotropic and linear elastic, Hook’s law is simplified to 
(in tensor form):  
 𝝈 =  𝜆 𝑘𝑘𝑰 + 2𝜇𝜺, (30) 
where 𝜆 and 𝜇 are Lame’s constants. The Lame’s constants are defined in terms of the 
stiffness (Young’s modulus, 𝐸) and the incompressibility (Poisson’s ratio, 𝜐): 
 
𝜆 =  
𝜐𝐸
(1 +  𝜐)(1 − 2𝜐)
, 𝜇 =  
𝐸
2(1 + 𝜐)
. (31) 
Equations 29 and 30 can fully describe the mechanical behavior of an isotropic linear 
elastic material under external forces. 
1.8.2 Hyperelasticity 
Many of the materials do not exhibit linear elastic response under external loading 
conditions. The nonlinear behavior of materials can be attributed to either or a 
combination of two mechanisms: intrinsic nonlinearity, and geometric nonlinearity. 
Hyperelasticity is used to explain the mechanical behavior of materials involving both 
mechanisms. Intrinsic nonlinearity, as the name suggests, is due to intrinsic mechanical 
properties that are defined by the properties of the material constituents. Materials with 
intrinsic nonlinearity are described by a nonlinear relationship between the Cauchy 
stresses and the strain tensor components under loading. Geometric nonlinearity arises 
from the change in the mechanical response caused by a force equilibrium alteration 
resulting from change in the material geometry. The change in the material geometry 
typically occurs when the material undergoes large deformations (strains > 5%) due to 
external loading, and results in a redistribution of forces within the material.  
In hyperelastic materials, the mechanical behavior is characterized in terms of a strain 
energy function, because hyperelastic materials may store deformation work as elastic 
energy (strain energy). The strain energy function is therefore defined in the deformation 
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gradients (𝐹) space, as energy per unit volume. The constitutive law of the material is 
derived according to the strain energy function, and for that purpose we can write the 
equation that relates the Cauchy stress tensor (𝝈) to the density energy function (𝑈(𝑭)) 
and the deformation gradient tensor (𝑭) and its determinant (𝐽): 
 
𝝈 = 𝐽−1𝑭
𝑑𝑈(𝑭)
𝑑𝑭
. (32) 
When the hyperelastic material is isotropic, the determinant of deformation gradient is 
one, and the above equation in this case becomes:  
 
𝝈 =  −𝑝𝑰 +  𝑭
𝑑𝑈(𝑭)
𝑑𝑭
, (33) 
where 𝑝 is an indeterminate Lagrange multiplier. The constitutive law for the isotropic 
hyperelastic materials can be derived from the above equation in terms of the strain 
energy function as:  
 
𝝈 = 2𝐽−1 [𝐼3
𝜕𝑈
𝜕𝐼3
𝑰 + (
𝜕𝑈
𝜕𝐼1
+ 𝐼1
𝜕𝑈
𝜕𝐼2
)𝑩 − 
𝜕𝑈
𝜕𝐼2
𝑩2], (34) 
where B (not to be confused with B in Eq. 25) is the left Cauchy-Green deformation 
tensor, defined in terms of the deformation gradient tensor as:  
 𝑩 = 𝑭𝑭𝑇 . (35) 
The strain energy function (𝑈) is a function of 𝐼1, 𝐼2, and 𝐼3, i.e. the strain invariants of 
the Cauchy-Green deformation tensors: 
 𝐼1 = 𝑡𝑟(𝑩) =  𝜆1
2 + 𝜆2
2 + 𝜆3
2 (36) 
 𝐼2 = 0.5 [(𝑡𝑟(𝑩))
2
− 𝑡𝑟(𝑩𝟐)] =  𝜆1
2𝜆2
2 + 𝜆1
2𝜆3
2 + 𝜆2
2𝜆3
2 (37) 
 𝐼3 = det(𝑩) =  𝐽
2 = 𝜆1
2𝜆2
2𝜆3
2. (38) 
In the above equations, 𝜆𝑖 , 𝑖 ∈ {1,2,3}, are the principal stretches.   
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Using Eq. 34, the constitutive law for a material can be derived for a given strain energy 
function. There are several different hyperelastic models that are represented by different 
strain energy functions. These different hyperelastic models are used to characterize the 
various mechanical behaviors of nonlinear elastic materials. In ABAQUS (the finite 
element solver that we used in this project), several hyperelastic forms are implemented, 
including: Arruda-Boyce, Marlow, Mooney-Rivlin, Neo-Hookean, Ogden, polynomial, 
reduced polynomial, Van der Waals, and Yeoh. The appropriate strain energy form for a 
material must be chosen based on mechanical test data. In this project, the Yeoh 
hyperelastic form was chosen to model the mechanical behavior of the lung tissue under 
deformation. The Yeoh strain energy function is described as:  
 
𝑈 = ∑(𝐶𝑖0(𝐼1 − 3)
𝑖 + 
1
𝐷𝑖
 (𝐽 − 1)2𝑖) ,
3
𝑖=1
 (39) 
where 𝐶10, 𝐶20, and 𝐶30 are the hyperelastic parameters and 𝐷1, 𝐷2, and 𝐷3 are the 
incompressibility coefficients. From the strain energy function and Eqs. 34 to 38, the 
stress-strain relationship can be obtained for the Yeoh hyperelastic form. 
1.9 «Inverse Problem» 
Using the complete description of a system from the governing physical theories, we can 
make predictions of the outcome of measurements. Predicting the measurement results of 
a system is known as the forward problem. On the other hand, using the results of 
measurements of a system to infer the values of parameters that describe the system is 
referred to as inverse problem. Unlike the forward problem, the inverse problem does not 
typically have a unique solution. In this work, to develop the biomechanical model of the 
lung based on the information from 4DCT, we have designed and implemented an 
inverse problem formulation. The parameters of the lung biomechanical model (the 
forward model) are found based on the information from 4DCT (results of 
measurements). For more detailed information on the inverse problem, see Section 2.2.3. 
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1.10 «Research Objectives»  
The work presented in this thesis is mainly focused on two objectives: 
1. Development of an accurate lung biomechanical model for tumor motion and 
deformation estimation by incorporating pathology-induced heterogeneity. 
2. Development of a 4DCT-based ventilation imaging technique using a 
biomechanical model-based image registration and an accurate air segmentation 
algorithm, as well as validation of the proposed ventilation imaging technique 
using hyperpolarized 3He MR. 
1.11 «Thesis Outline»  
This thesis is organized to include four chapters. The current chapter is dedicated to 
introduction and background, while the following two chapters describe the details of the 
work towards achieving the two main objectives mentioned in the above section, 
followed by the final chapter which is dedicated to summary and concluding remarks.  
1.11.1 Chapter 2: A Patient-Specific Heterogeneous Biomechanical 
Model of the Lung for Accurate Tumor Motion Estimation  
In this chapter, we describe details of the work towards achieving the first objective of 
the thesis. A patient-specific lung biomechanical model is developed from 4DCT scans. 
This lung biomechanical model is patho-physiologically realistic as it incorporates the 
heterogeneity in the lung tissue mechanics caused by co-existing chronic obstructive 
pulmonary disease (COPD). Advanced image processing methodologies such as semi-
automated segmentation of the lung images, free-form deformation image registration 
algorithm, semi-automated boundary conditions extraction, and COPD phenotypes 
quantification algorithm were designed and implemented and/or employed to extract the 
information from 4DCT scans, required to build the biomechanical model. An inverse 
problem formulation was designed and employed to obtain the parameters of the 
biomechanical model, e.g. the coefficients determining the amplitude of the pressure that 
inflates the lungs, and the mechanical properties of the lung tissue affected by COPD 
phenotypes. The lung biomechanical model is used to estimate the motion and 
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deformation of the tumor. The simulation results were compared against the actual 
location and shape of the tumor extracted from 4DCT using measures of similarity and 
distance. The high accuracy of the model for tumor motion and deformation estimation 
indicates successful achievement of the first objective of the thesis.   
1.11.2 Chapter 3: 4DCT Ventilation Imaging Using Biomechanical 
Model-based Deformable Registration 
In this chapter, we explain the details of the work towards achieving the second objective 
of the thesis. We developed a 4DCT-based ventilation imaging technique using a novel 
method that utilizes a biomechanical model-based DIR along with an accurate air 
segmentation algorithm. 4DCT scans of patients diagnosed with NSCLC and planned for 
RT were used to build patient-specific biomechanical models of the lungs. In this model, 
the lung geometry used for finite element (FE) meshing was acquired from segmenting 
the CT volume at end-exhalation. Loading was defined in terms of the transpulmonary 
pressure expanding the lungs. Boundary conditions consisted of the diaphragm motion 
and anatomical fixed points for each patient. The pressure amplitude and mechanical 
properties of various tissue volumes of the lung were found through an optimization 
algorithm designed to maximize the accuracy of the biomechanical model. The 
biomechanical model was used to deformably register the end-exhale scans to the end-
inhale ones. The biomechanical model-based DIR tracks air motion in the lung. The air 
segmentation algorithm, previously developed in our lab and enhanced in this work, 
found subject-specific thresholds for the inhalation and exhalation CT scans. This air 
segmentation algorithm also accounts for the partial volume effect, hence providing 
accurate estimations of the air volume inside the voxels. Having the air motion from DIR, 
and the air volume in each voxel, we can calculate the ventilation. To have a more 
accurate estimate of ventilation, we also took into account the regional volume expansion 
due to the inflow of air. We used the change in the volume of the mesh elements during 
finite element analysis to obtain the volume expansion at voxel level. The final 4DCT 
ventilation images were qualitatively and quantitatively compared against 3He MR 
images for validation.  
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1.11.3 Chapter 4: Discussion and Conclusion 
In the final chapter, we summarize the findings of the thesis, and discuss the limitations 
of the proposed algorithms. We also discuss possible future directions and suggestions 
for further studies. This section lastly concludes this dissertation.  
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Chapter 2  
2 « A Patient-Specific Heterogeneous Biomechanical 
Model of the Lung for Accurate Tumor Motion 
Estimation  » 
Currently, one of the main components of lung cancer treatment is radiation therapy (RT) 
which suffers from inaccuracies caused by the complex intrafraction respiratory motions. 
One potential solution towards addressing this challenge is to develop a lung 
biomechanical model capable of predicting the tumor’s motion/deformation. Chronic 
obstructive pulmonary disease (COPD) commonly coexists with lung cancer and is 
associated with extensive heterogeneity in the lung parenchyma; however, current 
methods lack this key component. In this work, we have developed an accurate lung 
biomechanical model that accounts for COPD-induced heterogeneities in the lung 
structure. Four-dimensional computed tomography (4DCT) images were used to build a 
patient-specific finite element (FE) model, and to identify inhomogeneity inside the 
model. Mechanical properties of pathological volumes inside the lung, and the maximum 
amplitude of the pressure driving the respiratory motion are determined through an 
optimization algorithm that aims at maximizing the similarity between the actual and 
simulated tumor and lung volume images. Results obtained in this work suggest that the 
accuracy of the tumor motion estimation model increases considerably when 
incorporating the patho-physiological heterogeneity, compared to the homogeneous 
model counterpart. 
2.1 « Introduction » 
Lung cancer remains the most common type of cancer affecting men and women, both in 
terms of incidence and mortality (1). Concurrent chemotherapy and radiation therapy 
(RT) is the current standard treatment for inoperable non-small cell lung cancer 
(NSCLC)(1–3). Stereotactic body radiation therapy (SBRT) is a high-precision treatment 
technique for extracranial tumors that delivers potent doses of highly focused radiation 
beams during a single or a few radiation fractions (4). Recently developed advanced 
SBRT methods such as intensity modulated RT (IMRT) and volumetric modulated arc 
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therapy (VMAT), aim at increasing the tumor control probability (TCP), and lowering 
normal tissue complication probability (NTCP) by delivering a more accurate and highly 
conformal radiation dose (5,6). IMRT utilizes forward or inverse radiation treatment 
planning to determine and deliver the necessary dose distribution through the use of 
multileaf collimators (7). VMAT is a more advanced type of IMRT that decreases the 
delivery time by applying the dose in a single gantry arc movement and improves the 
dose conformality by using the full 360° range of gantry rotation (8,9).  However, 
respiratory motion can cause inaccuracies in RT, resulting in higher probabilities of 
treatment complications such as irradiating normal tissue and undesirable dose 
distribution in the target tumor (7,10). Methods have been proposed to reduce such 
inaccuracies in RT, including: motion encompassing (11), breath-hold techniques (12), 
and gating the radiation beam with the breathing cycle (13,14). Each of these methods 
suffer from inherent limitations. In motion encompassing, the planning target volume is 
expanded to encompass the entire clinical target volume, resulting in a higher radiation 
dose delivery to normal tissue. Breath-hold methods are not usually well tolerated by 
lung cancer patients. Gated radiotherapy procedures are intrinsically associated with a 
conflict between the gating efficiency and gating window time, and longer radiation 
sessions. This problem is particularly of importance in IMRT systems where the 
treatment times are inevitably longer. 
An alternative solution to improve the precision in radiation delivery is to synchronize 
the radiation beam with the tumor motion. Accordingly, strategies to account for 
respiratory motion that provide accurate information regarding real-time shape and 
location of the target tumor are in demand. Intensity-based deformable image registration 
(DIR) methods have been employed to estimate the deformation field of the lung and the 
respiratory tumor motion for dose calculation and treatment planning purposes (15–17). 
However, the application of DIR methods in real-time tumor tracking is limited to a few 
studies. Li R. et al. adapted deformable image registration (DIR) in conjunction with 
simultaneous x-ray imaging to estimate the lung tumor motion and deformation (18); 
however, the extra radiation dose imposed to the patient due to the x-ray imaging in these 
methods has raised some concerns (19). In addition, intensity-based DIR methods are 
solely based on four-dimensional computed tomography (4DCT) image data. These 
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methods do not take into account the physical properties or physiological mechanisms 
involved in breathing. Therefore, they are prone to errors associated with non-uniqueness 
of the resulting displacement field, and registration errors in areas with low image 
contrast. Handling the sliding motion of the lungs can also be challenging for motion 
estimation using intensity-based DIR methods (20,21). 
Biomechanics-based computational modelling is another commonly used approach for 
respiratory tumor motion estimation. In contrast to DIR, biomechanics-based 
computational models encompass certain aspects of breathing dynamics, rendering this 
approach more robust and realistic (22–26). Patient-specific biomechanical models of the 
lung that use thoracic image data to extract the geometry and boundary conditions have 
previously been proposed (22,23,26,27). Several studies investigated the effects of model 
parameters including the mechanical properties (27–29), and boundary conditions (25) on 
modeling accuracy. Recently, hybrid hierarchical approaches have been proposed, in 
which finite element (FE)-based biomechanical models are used in conjunction with 
intensity-based DIR methods to predict deformation field of the lung in a respiratory 
cycle (21,30,31). 
Biomechanical modeling of the lung is capable of respiratory tumor motion estimation 
without requiring simultaneous imaging during RT or implanting invasive fiducial 
markers inside the tumor. Our group recently proposed a hybrid motion model for real-
time estimation of tumor location/geometry during respiration (32). The proposed method 
translates the chest surface motion data obtained by optical tracking markers to the tumor 
location/geometry, using the patient-specific biomechanical model of the lung and a 
predictive function. A realistic and accurate biomechanical model of the lung is, 
however, required in this method for real-time tracking of the tumor with a desired 
precision. 
Tissue mechanical properties including tissue stiffness and incompressibility, are 
important features of a biomechanical model determining its behavior under loadings. 
The air volume inside the lungs varies significantly during a respiration cycle, therefore, 
changes in tissue incompressibility is expected. Shirzadi et al. were first to investigate the 
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variations of incompressibility of the lung throughout respiration (29).  Their results 
demonstrated that accounting for variable incompressibility throughout respiration in a 
biomechanical model of the lung leads to higher accuracy of tumor motion estimation.  
More than 65% of lung cancer patients also suffer from chronic obstructive pulmonary 
disease (COPD) (33,34). COPD is a heterogeneous disease, characterized by multiple 
phenotypes including small airways disease (SAD) and parenchymal destruction 
(emphysema) that cause changes in the structure and mechanical properties of the 
affected lung tissue (35–38). A characteristic manifestation of emphysema is the 
interactions that occur between the immune system and the mechanical properties of the 
lung parenchyma at the microstructure level. The former causes inflammatory responses 
resulting in tissue remodeling, and therefore alterations in the mechanical properties of 
the affected areas in the lung tissue under repeated breathing cycles. A biomechanical 
model that accounts for local changes in tissue material properties potentially results in a 
more realistic motion estimation. Although few studies have been conducted to measure 
mechanical parameters of the lung tissue (39,40) or to evaluate the effect of changes in 
tissue mechanical properties on the model accuracy (23,41,42), to our knowledge, a 
tumor motion/deformation estimation model accounting for pathology-induced local 
changes in mechanical properties of the lung has not been reported. 
In this study, we propose a novel biomechanical model of the lung for respiratory tumor 
motion prediction that accounts for pathology-induced heterogeneities within the lung 
tissue. For this purpose, a patient-specific FE model of the lung was developed using 
4DCT image data. The pathological regions pertaining to COPD phenotypes were 
quantified using the CT image data. Tissue sub-types pertaining to healthy and various 
pathological phenotypes were considered in the model. The CT image of the lung at end-
exhalation (EE) was registered to the CT image of all phases of respiration (e.g. end-
inhalation: EI) using the FE model by optimizing the parameters of loading and 
mechanical properties of the tissue sub-types.  
The effect of incorporating pathology-induced heterogeneity on the model performance is 
investigated by comparing the accuracy of the tumor motion estimation of the 
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heterogeneous model with that of a homogeneous counterpart. Results of the similarity 
measures between the simulated and actual tumor volumes, as well as the average 
landmark error demonstrated that incorporating the pathology-induced tissue 
inhomogeneities can improve the model accuracy and reliability considerably. 
2.2 « Materials and Methods » 
2.2.1 Data Acquisition 
This research was performed in accordance with the institutional research ethics board 
approval. 4DCT respiratory image sequences of 5 patients were acquired as part of the 
FLAIR trial (10). Patients were diagnosed with NSCLC and planned for IMRT or 
volumetric-modulated arc therapy (VMAT) using PINNACLE (v9.6) Radiation Therapy 
Planning System (Philips Medical Systems, Fitchburg, WI). Patients were scanned using 
a 16-slice Philips Brilliance Big Bore CT scanner (Philips Medical Systems) operating in 
helical mode. The scan parameters were: 120kVp and 400mAs/slice for tube potential 
and current, respectively. The intra-slice pixel size of the data varied from 1.0 mm × 1.0 
mm to 1.1 mm × 1.1 mm, and the slice thickness was 3 mm for all scans.  
The 4DCT images were sorted into 10 respiratory phases using the Real-time Position 
ManagementTM system. The phases were labeled as: 0%, 10%, 20%, etc. to 90%, with 
0% denoting the EI phase and 50% denoting the EE phase. In this study, efforts were 
made to include patients with various tumor sizes and locations inside the lungs to 
explore the reliability and robustness of the biomechanical model. The average tumor 
size was 18.1 cm2, ranging from 4.1 cm2 to 61.9 cm2. In addition, the extent of COPD-
related phenotypes including gas trapping and airway wall destruction varied between the 
patients. 
2.2.2 Patient-specific Biomechanical Model 
To develop the patient-specific biomechanical model, the lung geometry, tissue 
mechanical properties, loadings, and boundary conditions are required. The 
heterogeneous and homogeneous models were similar in terms of the procedures 
involved in obtaining the model geometry, boundary conditions, and spatial pattern of the 
57 
 
loading. In the heterogeneous model, areas affected by either of the COPD phenotypes, 
the tumor, and the healthy lung parenchyma were assigned different mechanical 
properties. In the homogeneous model the entire lung parenchyma was modeled with one 
set of mechanical properties, with only the tumor assigned a separate set of properties. 
Further details on each model have been provided below. 
2.2.2.1 Patient-specific Model Geometry 
The 3D CT volume at EE (50%) phase was used to obtain the model geometry for each 
patient. The lungs were segmented using a region growing-based segmentation method 
followed by opening and closing operations for smoothing purposes. The automatic 
segmentation was an extension to the semi-automatic algorithm previously developed by 
our group (29,43). The 3D model of the lung was created from the closed lung 
segmentation mask using the open source 3D Slicer software package (44). The IA-
FEMesh software package (MIMX, Iowa city, IA, USA) was used to generate volumetric 
FE mesh of the lung with 8-node hexahedral elements. The FE analysis was performed 
using the ABAQUS/Standard software (ABAQUS Inc., Pawtucket, RI). 
2.2.2.2 Loadings and Boundary Conditions  
In a respiratory cycle, the lungs start to expand from EE in response to 1) contraction of 
the diaphragm, and 2) contraction of external intercostal muscles that expands the chest 
cavity, consequently resulting in a drop in the transpulmonary pressure, PT. At EI, the 
respiratory muscles (diaphragm and external intercostal) relax, causing the diaphragm to 
return and the ribcage to fall. This leads to an increase in the PT, forcing the air out of the 
lungs. The extent of expansion, and therefore the PT varies for different phases of 
respiration. In addition, PT is not spatially uniform on the lung surface. Accordingly, in 
the biomechanical model, the loadings were defined in terms of the net pressure required 
to expand the lungs from relaxed phase (EE), to the target phase of respiration, i.e. the PT. 
The PT was applied with a linearly increasing gradient in the posterior to anterior 
direction.  For each patient, the maximum pressure amplitude for each phase of 
respiration was estimated through an optimization algorithm. Details on the optimization 
process, the cost function, and the evaluation criteria are described in Section 2.2.3. 
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The drop in the PT mainly enlarges the lungs in the medial-lateral (ML) and anterior-
posterior (AP) directions whereas the diaphragm is known to cause 60-80% of the 
thoracic cavity enlargement (60), and hence playing an important role in the lung 
expansion during inspiration. In this study, the displacement of the diaphragm resulting 
from its contraction was estimated through a non-rigid registration algorithm. A multi-
resolution free form deformation (FFD) algorithm was used to register the relaxed 
diaphragm at EE to the contracted diaphragm at other respiration phases. The resulting 
displacement field was then applied in the FE model as prescribed boundary condition at 
the bottom surface of the lung. Considering the fact that the diaphragm motion is a main 
source of the lung deformation in the superior-inferior (SI) direction, the precision of the 
diaphragm-driven prescribed boundary conditions is crucial. However, clinical 4DCT 
image data acquired for radiation therapy planning are often low contrast and include 
breathing-induced artifacts that affects image interpretation, especially within the areas 
close to the diaphragm surface as shown in Figure 2-1(45,46). Yamamoto T. et al. have 
investigated and classified the different types of artifacts attributed to internal motion of 
the organs during the 4DCT acquisition, and explained the complications such artifacts 
can cause in RT procedures (46). 
 
To evaluate the robustness of the proposed biomechanical model, cases with considerable 
artifacts on and near the diaphragm were included in this study. Although the FFD 
algorithm fails to register the EE diaphragm to that of another target phases (see Section 
(a) (b) (c) 
Figure 2-1. Examples of motion-induced artifacts in the dataset. The images show 
different types of artifacts as classified by Yamamoto et al. (a) Overlapping structure, (b) 
incomplete structure, and (c) duplicate structure. 
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2.3.2), it captures the relative spatial pattern of deformation. The major component of the 
diaphragm displacement is in the SI direction. To compensate for the partial registration 
due to image artifacts, the diaphragm displacement field was modified using an adaptive 
correction factor (𝐾𝐶𝐹) for the SI component of the estimated deformation field. The 𝐾𝐶𝐹 
was optimized for each target phase of respiration. Details of the applied optimization 
framework has been provided in Section 2.2.3.  
The respiratory lung motion in the chest cavity is constrained within regions of the lung 
apex and the lung-ribcage interface. To model such constraints and incorporate them as 
boundary conditions in the biomechanical model, a semi-automatic image segmentation 
algorithm that uses information on lungs sliding motion was developed. The algorithm 
inputs the 3D CT volumes at extremities of respiration (50%, 0%, and 90%) and outputs 
3 label maps representing areas corresponding to fixed boundary conditions (constrained 
in all directions), ML-AP constrained, and SI constrained. 
2.2.2.3 Mechanical Properties 
To investigate the effects of incorporating pathology-induced heterogeneities on the 
model performance, both homogeneous and heterogeneous models were developed for 
each patient. The model geometry, loading configuration, and boundary conditions were 
similar for both models. 
2.2.2.3.1 Homogeneous Biomechanical Model 
As for the mechanical properties of the homogeneous model, two material types were 
defined: lung parenchyma, and the tumor. The tumor was modeled as a linear elastic 
material. Taking into account the large deformation of the lungs during respiration the 
lung tissue was modeled as hyperelastic, described by Yeoh strain energy density 
function (47): 
𝑈 =  ∑𝐶𝑖0(𝐼1̅ − 3)
𝑖 + ∑
1
𝐷𝑘
(𝐽𝑒𝑙 − 1)2𝑘
3
𝑘=1
 
3
𝑖=1
, (1) 
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where 𝑈 is the strain energy potential, 𝐼1, 𝐼2, and 𝐼3 are strain invariants (invariants of left 
Cauchy‐Green strain tensor), and 𝐽𝑒𝑙 is the elastic volume ratio (a fraction of the total 
volume ratio 𝐽 in constant temperature conditions). The model parameters 𝐶𝑖0(𝑖 = 1: 3) 
and 𝐷𝑘  (𝑘 = 1: 3) determine the material’s mechanical response and its variations with 
respect to strain. The coefficients 𝐶𝑖0(𝑖 = 1: 3) for the lung tissue were calculated by 
fitting the experimental stress-strain data found in the literature (40). 𝐷𝑘 parameters 
mainly describe the material incompressibility and its dependence on deformation. The 
tissue incompressibility modeling is described in Section 2.2.2.3.3. 
2.2.2.3.2 Heterogeneous Biomechanical Model 
To model the pathology-induced heterogeneities inside the lung parenchyma, the extent 
of each COPD phenotype was first quantified in the 4DCT images, using a well-known 
attenuation-based method. In this method, the image voxels in the EI scan with 
attenuation values lower than -950 Hounsfield Units (HU), denote emphysema (48–52). 
Similarly, areas in the EE image with attenuation values lower than -856 HU represent air 
trapping. A deformable image registration was used to register the EI scan to the EE 
counterpart. The registration transformation was applied to map the emphysematous 
voxels to the EE image. Finally, the areas affected by SAD were determined as the air 
trapping voxels that are not caused by emphysema as illustrated in Figure 2-2.  
The diseased volumes were subsequently incorporated in the FE analysis by assigning 
different mechanical properties. The lung parenchyma was classified into 4 material sub-
types: healthy, emphysematous, affected by SAD, and the tumor. The Yeoh hyperelastic 
model was used to model the mechanical properties of healthy and diseased tissues 
except the tumor. The elasticity coefficients (𝐶10, 𝐶20, and 𝐶30) for the healthy tissue 
were the same as that of the lung parenchyma in the homogeneous model. The Yeoh 
hyperelastic coefficients for each of the emphysema and SAD tissue sub-types were 
optimized using an algorithm described in Section 2.2.3. 
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2.2.2.3.3 Incompressibility Variation during Respiration 
As previously described in the studies conducted by our group (29,43), lung tissue 
incompressibility varies throughout respiration as the air content within the tissue 
changes substantially between the inhalation and exhalation phases. In the previous 
studies the variations in incompressibility of lung tissue was modeled by optimizing 
Poisson’s ratio for each phase of respiration. Alternatively, the Yeoh hyperelastic model 
applied in this study can describe the mechanical behavior of the lung at all respiration 
phases with one set of 𝐶𝑖0 and 𝐷𝑘  parameters. Specifically, the 𝐷𝑘  parameters describe 
the changes in tissue incompressibility with respect to variations in deformation during 
respiration that are proportional to the air content of the lung. Therefore, optimizing the 
Figure 2-2. Axial view of slices from 4DCT data showing emphysema (green), SAD 
(yellow), and the tumor (red). Healthy lung parenchyma is represented by blue. (a) 
Patient #1, with extensive SAD, less emphysema. (b) Patient #2, with extensive SAD, 
less emphysema, very large tumor. (c) Patient #3, the tumor is located further from 
COPD-affected volumes. (d) Patient #4, very less SAD and no emphysema. (e) Patient 
#5, with extensive SAD and emphysema, tumor in proximity of affected areas. 
(a-1) (b-1) (c-1) (d-1) (e-1) 
(a-2) (b-2) (c-2) (d-2) (e-2) 
62 
 
𝐷𝑘 parameters in the model accounts for the variable tissue incompressibility as a result 
of changes in air volume of the lung during respiration. 
2.2.3 Optimization Framework 
A number of the biomechanical model parameters including maximum pressure 
amplitude, diaphragm registration correction factor and the tissue mechanical properties 
were optimized for each patient. The maximum pressure amplitude and the diaphragm 
registration correction factor are parameters that depend on the phase of respiration and 
should be optimized for each target phase separately. However, some of the mechanical 
properties are phase-independent and must hold a consistent value throughout all phases 
for each patient. The phase-independent mechanical properties include: the elasticity 
parameters (𝐶𝑖0s) for diseased sub-types in the heterogeneous model, and the 
incompressibility parameters of the lung tissue for both the homogeneous and 
heterogeneous models. On this basis, two optimization algorithms, one for the phase-
dependent and another for the phase-independent parameters were developed and used in 
turn for both the homogeneous and heterogeneous models.  
The first optimization algorithm was implemented in MATLAB (MathWorks, USA) for 
computing the phase-dependent parameters; it is shown in Figure 2-3.The 4DCT scans 
were segmented to obtain the lung and tumor geometries at 50% (𝜙50) and each target 
phase (𝜙𝑖 , 𝑖 ∈ {0, 10,20,30,40,60,70,80,90}). Lung geometry at 𝜙50 was used as the 
reference geometry to generate FE mesh for the analysis. The iterative FE analysis was 
started using initial values for the transpulmonary pressure (𝑃𝑖 = −1.8 𝑐𝑚𝐻2𝑂) and the 
diaphragm registration correction factor (𝐾𝐶𝐹𝑖 = 1) for each phase (𝜙𝑖). Since the 
mechanical properties for the heterogeneous tissue sub-types are unknown at this point, 
we started with the homogeneous material properties, simulating the deformation of the 
lungs expanding from 𝜙50 to 𝜙𝑖, and generating registered images, to 𝜙𝑖. The 
optimization cost function was formulated to minimize the Hausdorff surface-to-surface 
distance (𝐻𝐷) between the actual (𝑇𝑟𝐴𝑗) and simulated (𝑇𝑟𝑆𝑗) tumor images, while 
maximizing the Normalized Mutual Information (𝑁𝑀𝐼) within the lung in the actual 
(𝐿𝑔𝐴𝑗) and simulated (𝐿𝑔𝑆𝑗) images: 
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𝑓𝐶(𝑃𝑖 , 𝐾𝐶𝐹𝑖) = 𝜆 × 𝐻𝐷 (𝑇𝑟𝐴𝑗 , 𝑇𝑟𝑆𝑗) + 
𝛾
𝑁𝑀𝐼(𝐿𝑔𝐴𝑗 , 𝐿𝑔𝑆𝑗)
, (2) 
where 𝜆 and 𝛾 are constants used as weight factors and were chosen to regulate the 
relative effect of each measure (𝐻𝐷 and 𝑁𝑀𝐼) on the optimization based on their 
importance and the range by which they vary.  
After conducting this optimization step on the homogeneous model for all phases of 
respiration individually, we can utilize the resulting pressure values in the second 
optimization step for computing the phase-independent parameters, i.e. elasticity 
properties and incompressibility. However, in determining the deformation, the pressure 
and the mechanical properties are interrelated. Accordingly, fixing the pressure values to 
what is obtained from the first step of the optimization when optimizing for mechanical 
properties in the second step may lead to complications such as falling into local minima. 
To account for the interrelation of pressure and mechanical properties, we must allow for 
Figure 2-3. Flowchart showing the first optimization step. The 4DCT data is used to 
segment the lung and the tumor at phase EE (𝝓𝟓𝟎) and the target phase, for which the 
maximum pressure amplitude (𝑷𝒊) and the diaphragm registration correction factor 
(𝑲𝑪𝑭𝒊) are optimized. The homogeneous finite element model is used in this step to 
deform the reference geometry to the target counterpart. The cost function 𝒇𝑪 regulates 
the updating of the parameters to ensure the best registration. 
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the pressure to adjust during the second optimization process. In this regard, the pressure 
values resulting from the first optimization are employed to form a parametric 
representation of the pressure using Fourier series (Eq. 3). The Fourier representation 
serves as a proper estimation of the pressure at each phase. This parametric representation 
allows for optimization of the pressure through optimizing for the Fourier coefficients 𝑐1 
and 𝑐2. Therefore, amplitude of the pressure can be optimized in the second optimization 
step as a function of time (i.e. respiration phase): 
 
𝑃𝑇(𝑡, 𝑐1, 𝑐2) = 𝑐1 ∑(𝑎𝑛 𝑐𝑜𝑠 𝑛𝜔𝑡) + 𝑐2 ∑(𝑏𝑛 𝑠𝑖𝑛 𝑛𝜔𝑡),
3
𝑛=0
3
𝑛=0
 (3) 
where 𝑡 is time (respiration phase), 𝜔 represents base frequency, and 𝑎𝑛 and 𝑏𝑛 are the 
relative amplitudes of different frequency components of sine and cosine functions.  
The second optimization step was developed and utilized to compute the phase-
independent parameters in both homogeneous and heterogeneous models. In both cases, 
𝑐1 and 𝑐2 (used to adjust the pressure) and the incompressibility parameters (𝐷𝑖) are 
optimized. In the heterogeneous model the hyperelasticity coefficients for different tissue 
material sub-types including 𝐶𝑖0𝐸𝑚𝑝ℎ𝑦𝑠𝑒𝑚𝑎  and 𝐶𝑖0𝑆𝐴𝐷are also optimized. Information from 
all phases of respiration are incorporated in each optimization iteration to accommodate 
for optimization of phase-independent parameters. The cost function used for 
optimization is consistent between the homogeneous and heterogeneous models. In each 
iteration of optimization, the HD between the tumor images, and the NMI between actual 
and simulated lung images for all target phases are calculated and combined as shown in 
Eq. 4:  
 𝑓𝐶(𝑐1, 𝑐2, 𝐷𝑖 , 𝐶𝑖0𝑘) 𝑖∈{1:3},
𝑘∈{𝐸𝑚𝑝ℎ𝑦𝑠𝑒𝑚𝑎, 𝑆𝐴𝐷}
=  𝜆 × √∑𝐻𝐷
2 (𝑇𝑟𝐴𝑗 , 𝑇𝑟𝑆𝑗)
𝑗
 +   
𝛾
√∑ 𝑁𝑀𝐼2 (𝐿𝑔𝐴𝑗 , 𝐿𝑔𝑆𝑗)𝑗
 (4) 
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2.3 « Results » 
The heterogeneous and homogeneous models were implemented using 4DCT data of 5 
patients. The model parameters were computed through the two-step optimization 
algorithm. The optimized models were used to register the EE scan to other respiration 
phases. The proposed algorithm is evaluated, and the accuracy of the homogeneous and 
heterogeneous models for registration are compared. 
2.3.1 Two-step Optimization Algorithm 
The Fourier parametric representation of the maximum pressure amplitude obtained from 
the first optimization step was evaluated in the first step. The coefficient of determination 
(𝑅2) and the normalized root mean square deviation (𝑁𝑅𝑀𝑆𝐷) of the Fourier estimation 
of pressure for each patient are given in Table 2-1. The accuracy of the Fourier fitting is 
reasonable for this application, because the estimated representation is used to assign 
initial values for the second step of optimization. 
Table 2-1 Evaluation results for the Fourier representation of optimized pressure. 
Patient # 𝑅2 𝑁𝑅𝑀𝑆𝐷 
1 0.9794 0.1845 
2 1 0 
3 0.9791 0.1233 
4 0.9672 0.1312 
5 0.9932 0.0621 
2.3.2 Diaphragm FFD Registration Algorithm  
Considering the important role of displacement boundary conditions determined by the 
diaphragm registration on the modelling accuracy, we assessed the functionality of the 
proposed method for correcting the diaphragm FFD registration. The registration 
correction factor (𝐾𝐶𝐹) is optimized for each respiration phase during the first 
optimization step. In some patients, the artifacts are more prominent than the others. 
Figure 2-4 shows an example of the substantial improvement in diaphragm registration. 
Figure 2-4(a) is the difference image between the source (EE phase) and target images 
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before registration, Figure 2-4(b) illustrates the same after registration with FFD 
algorithm, and Figure 2-4(c) shows the same after applying the 𝐾𝐶𝐹 to the deformation 
field.  
 
2.3.3 Tumor motion/deformation estimation and Registration 
Accuracy 
The accuracy of the image registration using the heterogeneous and homogeneous 
biomechanical models were evaluated using various criteria. To evaluate the accuracy of 
tumor registration, the tumor volumes from the actual and registered CT images were 
compared for each target phase of respiration using the Dice similarity coefficient, and 
Hausdorff surface-to-surface distance (HD). Figure 2-5 demonstrates the evaluation 
results of tumor registration for each patient.  
In all cases, the average Dice coefficient increased, and the HD decreased when the 
heterogeneous model was used, which shows the positive impact of incorporating the 
patho-physiological changes of the lung structure in the model. The extent to which the 
accuracy of tumor motion/deformation estimation improved by using the heterogeneous 
model was different among cases.  We calculated the percentage volume (%V) of COPD 
phenotypes (emphysema and SAD) in each case, as shown in Table 2-2. We also 
calculated the percentage improvement in the average measures of tumor 
motion/deformation accuracy (Dice and HD) when the heterogeneous model is used 
instead of the homogeneous model for each case. As show in Table 2-2, more tangible 
(a) (b) (c) 
Figure 2-4. Difference image between diaphragm at EE (50%) and EI (0%), (a) before 
registration, (b) after registration using FFD image registration, (c) after registration 
using the optimized 𝑲𝑪𝑭 parameter applied to the deformation field. 
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improvement in Dice and HD is observed with increased COPD severity. Patients #2, #3 
and #5 showed highest improvements in Dice coefficient, whereas Patients #1 and #4 did 
not benefit tangibly (<5% increase in Dice and <10% decrease in HD) from incorporating 
COPD-induced heterogeneity in mechanical properties.  Even though Patient #2 has a 
higher COPD severity compared to Patient #3 (emphysema and SAD combined), the % 
increase in Dice is lower for Patient #2. This is particularly attributed to the sensitivity of 
Dice coefficient to the size of the compared volumes. 
 
Figure 2-5. Comparing the results of tumor motion/deformation estimation between 
homogeneous and heterogeneous models. (a) Average Dice similarity coefficient and 
(b) average Hausdorff distance (HD) between actual and simulated tumors over all 
target phases.  
Table 2-2 The extent of COPD phenotypes represented in their percentage volume 
(%V), and the percentage improvement in measures of tumor motion/deformation 
estimation for each case.  
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The larger the tumor size, the less sensitive the Dice is to variations in the compared 
volumes. Patient #2’s tumor size is considerably larger than the Patient #3’s (4.2 cm3 vs 
61.9 cm3), and therefore the %increase in Dice smaller. The % decrease in HD is largest 
for Patient #2 with the highest COPD severity (emphysema and SAD combined), and is 
smallest for Patients #1 and #4 for with lowest COPD-affected %V.  
The accuracy of the tumor motion estimation during respiration was evaluated by 
comparing the displacement of the center of mass (CoM) of tumor in 4DCT scans with 
that obtained after registration using the homogeneous and heterogeneous FE models 
(Figure 2-6). The magnitude of tumor CoM motion during respiration is plotted 
separately for each case. The AP and ML components of tumors’ CoM motion were 
relatively small (compared to the SI component) and showed similar results for 
homogeneous and heterogeneous models. As shown in Figure 2-6 both homogeneous and 
heterogeneous models follow the magnitude of tumor’s CoM displacement, however, 
heterogeneous model shows superior performance. 
To assess the functionality of the proposed biomechanics-based method for lung image 
registration, we calculated landmarks registration error (LRE), as a standard measure of 
registration error (23,53) for 3 of the patients. LRE was defined as mean Euclidean 
distance between 30-40 pairs of landmarks throughout the lung, identified using 
bifurcation points in the source (EE, 50%) and the target images. Because manual 
landmarks identification is a time-consuming task, we used Patients #2, #3, and #5 as 
proof of concept. Table 2-3 shows the LRE before and after registration using the 
homogeneous and heterogeneous models for each patient.  
Comparing the LRE before and after the registration with either of the homogeneous or 
heterogeneous models shows the high accuracy of the biomechanical model-based 
registration proposed in this work.  
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Table 2-3 Average LRE for all patients before and after registration with homogeneous 
and heterogeneous models 
Patient # LREbefore (mm) 
After Registration 
LREHomogeneous(mm) LREHeterogeneous(mm) 
2 7.67 ± 3.32 2.77 ± 0.93 1.85 ± 0.91 
3 6.9 ± 4.28 2.55 ± 1.06 2.23 ± 1.10 
5 6.77 ± 4.12 2.51 ± 0.88 1.52 ± 0.90 
 
Figure 2-6. Actual tumor CoM motion magnitude and the simulated tumor CoM motion 
magnitude using homogeneous and heterogeneous models. 
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2.4 «Discussion» 
In this work a patient-specific biomechanical model-based image registration algorithm 
was proposed for lung cancer patients that mimics the breathing physiology and 
incorporates the pathophysiology of lung in patients with COPD. Specifically, changes in 
the structure of lung parenchyma as a result of different COPD phenotypes were 
considered in the biomechanical model. The results demonstrated that changes in the 
mechanical properties of the lung parenchyma due to COPD have considerable effects on 
the accuracy of biomechanics-based image registration algorithm. Particularly, the 
heterogeneous FE model resulted in higher accuracies for tumor motion/deformation 
estimation compared to its homogeneous counterpart in all patients, regardless of the 
variations in size and/or location of the tumor. In addition to the increase in average 
accuracy, the error bars are considerably smaller when the heterogeneous model is used 
for registration (Figure 2-5). Our method registers the CT image acquired at the EE phase 
to other phases of respiration by deforming the EE geometry. As one would expect, the 
lowest registration accuracies are observed when the required deformation is the largest, 
which is when the target phase for registration is the furthest respiration phase from EE 
(the source phase), i.e. the peak-inhale phases.  Therefore, the reductions observed in the 
error bars along with the increase in the average of the accuracy measures when the 
heterogeneous model is used implies increased accuracy of the model, especially for 
estimation of large deformation. Considering that lungs undergo large deformation during 
respiration, this observation highlights the impact of using optimized hyperelastic 
mechanical properties for healthy and pathological tissue sub-types in the FE model. 
The estimation of tumor displacement using either of the models closely followed the 
actual magnitude of tumor’s CoM displacement, and its components in all directions. 
This characteristic of the model is very important in the radiation therapy application 
because the model is capable of estimating the location of the tumor during all phases of 
respiration, as well as its shape. This is essential for developing intrafracture and 
interfracture tumor motion compensation systems.  
The proposed image registration technique can also be used for lung image registration in 
addition to tumor motion prediction. The proposed lung image registration shows similar 
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accuracy (as represented by LRE) to the current intensity-based DIR algorithms (54,55) 
and biomechanics-based image registration methods proposed elsewhere (53). For 
example, Han L. et al. proposed a hybrid DIR for lung peak CT pairs that combines a 
biomechanical of the lungs with a BSpline-based DIR (56). They showed that the 
resulting motion field describes the underlying physiology more realistically, and the 
accuracy of registration is improved compared to the intensity-based DIR algorithm (56). 
They reported an average target registration accuracy of 1.37 ± 0.89 mm for registering 
peak-inspiration CT pairs with 2.5 mm slice thickness and in-plane resolutions ranging 
from 0.97 mm × 0.97 mm to 1.16 mm × 1.16 mm.  
Respiration motion-induced artifacts cause inaccuracies in current thoracic image 
registration methods (57). The quality of the low-dose clinical CT scans including the RT 
treatment planning CTs are commonly limited by these artifacts. In this work, the 
physiology-inspired biomechanical model performance is not affected by the motion 
artifacts present in the dataset, suggesting the capability of the model to be used to 
process clinical CT data.  
The optimization algorithm maximizes the registration accuracy by finding the proper 
mechanical properties of the emphysematous and SAD-affected tissue, located based on 
the CT intensity values (HU). This method can potentially be used to provide in-vivo 
estimates of tissue mechanical properties of different regions of the lung characterized by 
different CT intensities. The estimated mechanical properties possibly provide 
supplementary information for tissue characterization in diagnostic and prognostic 
applications.  
One limitation of the current study is that in all investigated cases, the tumor is in the 
right lung. Modeling the motion of the tumors located in the left lung can be more 
challenging due to complexities caused by the interactions with the heart mechanics. Our 
group has developed and investigated a number of FE models for the heart (58,59). 
Future research directions may include integrating the heart and the lung FE models to 
obtain realistic biomechanics-based image registration for the left lung. 
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Chapter 3  
3 « 4DCT Ventilation Imaging Using Biomechanical 
Model-based Deformable Registration » 
3.1 « Introduction » 
Assessment of the lungs regional function represented by either or a combination of 
perfusion, diffusion, and ventilation has proven useful in many applications including 
lung cancer radiation therapy (1) and diagnosis of pulmonary abnormalities such as 
asthma and chronic obstructive pulmonary disease (COPD) phenotypes (2). Current 
radiation therapy treatment planning methods assume a homogeneous distribution of lung 
function and hence a homogeneous treatment response characterized by radiation dose 
distribution. However, many lung cancer patients have co-existing pulmonary 
dysfunctions that give rise to pulmonary function heterogeneity (3,4). Functional 
avoidance treatment planning that preferentially spares the functional lung tissue from 
radiation dose, has been tested in clinical trials, and has shown to 1) help reduce the 
incidence and the severity of radiation-induced lung injuries (e.g. radiation pneumonitis 
and pulmonary fibrosis) (5–8), and 2) enable target dose escalation for more effective 
treatments (9,10). In addition, monitoring changes in the lungs’ regional function during 
the course of radiation therapy can be used for evaluating treatment response (11). 
Regional function information has also shown to be useful in applications other than 
radiation oncology. For example information pertaining to regional distribution and 
severity of pulmonary diseases such as asthma and COPD phenotypes can be used to 
develop new therapies and improve existing therapeutic methods (12–14).  
Information on regional variations of the lung function can be found non-invasively by 
various imaging methods. Functional images can be directly generated using positron 
emission tomography (PET) (15) and single photon emission computed tomography 
(SPECT) (16). Hyperpolarized 3He magnetic resonance (MR) imaging has been used for 
imaging ventilation (2,17), 129Xe MR imaging can be used to obtain information on 
ventilation, perfusion, or gas exchange (18), and Xenon-enhanced computed tomography 
(CT) can provide a direct assessment of pulmonary ventilation(19). Four dimensional CT 
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(4DCT)-based ventilation imaging (CTVI) has recently emerged as a cost-effective and 
accessible alternative to the abovementioned modalities, with potentially higher spatial 
resolution compared to nuclear medicine ventilation imaging. CTVI is especially 
attractive in radiation therapy applications because it can be achieved using treatment 
planning 4DCT images acquired as part of the routine care in most centers (20). Clinical 
trials on CTVI-based functional avoidance planning are on-going, with the goal of 
reducing radiation toxicities (10,21). CTVI has also been used to improve the prediction 
of radiation pneumonitis and clinical toxicity. For example, Vinogradskiy et al. found a 
potential reduction in radiation induced toxicities (grade 2+ and 3+ pneumonitis) when 
CTVI-based functional avoidance planning was used instead of conventional anatomical 
planning (8). Moreover, dose-response assessment studies have been conducted by 
evaluating changes in the lung ventilation (as mapped by CTVI) between radiation 
therapy fractions (22,23) and after radiation therapy (11,24–26).  
Different methods have been proposed for CTVI, most of which consist of a “deformable 
image registration (DIR)” between the peak respiration CT pairs, and a “ventilation 
metric” (27,28). The accuracy of the DIR method used is a major determining factor in 
the CTVI accuracy, and hence its clinical benefits (29). Almost all previously proposed 
CTVI methods are founded on intensity-based DIR algorithms (27,28). Despite advances 
made in DIR methods, they are based solely on 4DCT image data, and are sensitive to 
motion artifacts that are frequently encountered in treatment planning 4DCT scans (30). 
There exist a few commercial DIR methods including Velocity (Varian Medical Systems, 
Palo Alto, CA, USA) and RayStation (RaySearch Laboratories, Stockholm, Sweden), 
some open DIR software packages such as Plastimatch (see www.plastimatch.org, last 
accessed on August. 2019) and Elastix (see http://elastix.isi.uu.nl/, last accessed on 
August 2019), and different in-house methods developed by research labs (27). Intensity-
based DIR algorithms do not take into account the physical properties or physiological 
mechanisms involved in breathing, hence are prone to errors associated with non-
uniqueness of the resulting displacement field and registration errors in areas with low 
image gradients. In addition, handling the sliding motion of the lungs can be challenging 
for motion estimation using intensity-based DIR methods (31,32).  
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Biomechanical models have been widely used alone or in combination with intensity-
based methods as alternative to DIR approaches (33,34). In contrast to intensity-based 
DIR, biomechanics-based computational models encompass certain physiological aspects 
of breathing dynamics rendering this approach more robust and realistic (35–38). Patient-
specific lung biomechanical models that use the thoracic image data to extract the lung’s 
geometry and boundary conditions have been previously proposed (34,39,40). Several 
studies investigated the effects of model parameters including the mechanical properties 
(39,41,42), and boundary conditions (38) on modeling accuracy. Recently, hybrid 
hierarchical approaches have been proposed, in which finite element (FE)-based 
biomechanical models are used in conjunction with intensity-based DIR methods to 
predict deformation fields of the lung in a respiratory cycle, and to register lung CT 
image pairs (43,44). For example, Han L. et al. proposed a hybrid biomechanical model-
based DIR for lung peak CT pairs, and showed that the resulting motion field describes 
the underlying physiology more realistically while the accuracy of registration was 
improved compared to the intensity-based DIR algorithm (43). In this study, we are 
proposing an accurate biomechanics-based DIR algorithm in conjunction with a 
sophisticated lung air segmentation algorithm for CTVI. To our knowledge, we are the 
first group to utilize biomechanical models in a CTVI application.  
With respect to a ventilation metric, the current CTVI methods are generally classified as 
either Hounsfield unit-based (DIR-HU) or Jacobian-based (DIR-Jac) methods, with a few 
studies reporting a combination of the two (27). The DIR-HU methods use changes in 
voxels intensity between the end-inhale and end-exhale breathing phases to calculate 
ventilation. The assumption for calculating ventilation based on DIR-HU is that the lung 
CT voxels intensity (CT numbers) comprise a linear combination of the CT number of 
water and that of air, both assumed to be constant (0 HU and -1000 HU, respectively) and 
therefore the fraction of air within each voxel can be described by a simple linear 
function (45). Uncertainties resulting from image noise, beam hardening, scanner 
calibration, and acquisition and reconstruction artifact, can render the assumption of 
constant CT numbers for tissue and air unreliable (46,47). Using a fixed linear 
relationship for all patients may lead to inaccurate estimation of the air volume, and 
hence the ventilation. Therefore, we are proposing the incorporation of an accurate air 
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volume calculation method that finds patient’s scan-specific values for air and tissue 
intensities based on an advanced thresholding algorithm (48,49).  
In addition, the DIR-HU methods do not take into consideration the respiratory changes 
in the lung volume. On the other hand, the DIR-Jac methods calculate ventilation based 
on the determinant of Jacobian of the transformation obtained from DIR of the lung CT at 
the end-inhalation phase to the end-exhalation phase image (50). This approach assumes 
that local partial derivatives of the deformation field are related to the volume changes of 
the corresponding voxel. It does not consider changes in the voxels’ intensity that can be 
indicative of changes in the fractional air volume. A CTVI that accounts for both changes 
in voxels’ intensity and regional expansion can provide more realistic information on 
ventilation.  
We are proposing a CTVI technique that combines an accurate biomechanical model-
based DIR, with an advanced patient-specific air volume estimation algorithm. In this 
CTVI technique, we also correct for regional volume expansion based on information 
obtained from the lung biomechanical model. We evaluate the clinical utility of the 
proposed CTVI technique by qualitatively and quantitatively comparing the ventilation 
images with hyperpolarizd 3He MRI of the same patients, used in a clinical trial for 
functional avoidance planning (3).  
3.2 « Materials and Methods » 
An overview of the proposed CTVI algorithm is shown in Figure 3-1. Treatment planning 
4DCT scans of three patients (see Section 3.2.1.1 for details on data acquisition) are used 
in this CTVI study. Using a lung biomechanical model, we deformably register the end-
exhale (EE) lung CT image to the end-inhale (EI) image. The biomechanical model-
based DIR involves reconstruction of the deformed EE image. After the registration step, 
each voxel in the EI image corresponds to a voxel in the deformed EE image. These two 
images are fed into an air segmentation algorithm where the distribution of air within 
each image is found using an advanced thresholding method that incorporates the partial 
volume effect. The air distribution in the deformed EE image is then corrected with 
respect to the regional volume expansion information, obtained from the volume change 
83 
 
of corresponding finite elements calculated using finite-element (FE) analysis. The CTVI 
is then calculated as the difference between the amount of air in the EI voxels and the 
corrected amount of air in the corresponding EE voxels. In the following sections, each of 
the abovementioned steps are described in detail.  
3.2.1 Data Acquisition 
This research was performed in accordance with the institutional research ethics board 
approval. Three patients from the FLAIR trial were included in this study (3). Patients 
were diagnosed with non-small-cell lung cancer. Treatment planning 4DCT image 
sequences, 3He and 1H MR, and 3DCT scans of the patients were used in this study.  
3.2.1.1 Treatment Planning 4DCT 
A 16-slice Philips Brilliance Big Bore CT scanner (Philips Medical Systems) operating in 
helical mode was used with scan parameters: 120kVp and 400mAs/slice for tube 
potential and current, respectively. The intra-slice pixel size of the data varied from 0.98 
mm × 0.98 mm to 1.11 mm × 1.11 mm among patients, and the slice thickness was 3 
Figure 3-1. The proposed CTVI workflow. The peak-inspiration CT scans are registered 
using the biomechanics-based DIR. The air segmentation algorithm finds the partial 
volume of air in each scan after registration. The regional volume expansion is corrected 
for before the CTVI is calculated as the difference between air volumes in end-inhale and 
end-exhale voxels.  
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mm for all scans. The 4DCT images were sorted into 10 respiratory phases using the 
Real-time Position ManagementTM system. 
3.2.1.2 MR Image Data Acquisition 
MR imaging was performed using a whole body 3.0 T MR750 system (GE Health Care, 
Milwaukee, WI) using a gradient amplitude of 1.94 G/cm and a single channel, rigid 
elliptical transmit/receive chest coil (Rapid Biomedical GmbH, Wuerzburg, Germany). 
3He gas was prepared using a polarizer system (HeliSpin, Polarean, Durham, NC, USA) 
where polarization levels of approximately 40% were achieved. Hyperpolarized 3He was 
diluted with medical-grade N2 gas. Subjects were instructed to inhale the 
3He/N2 gas from 
functional residual capacity (FRC), from a 1L Tedlar® bag (Jensen Inert Products, FL, 
USA), and images were acquired during a 16-second breath hold. Coronal (anatomical) 
1H MRI was performed using the whole-body radiofrequency coil and 1H fast-spoiled, 
gradient-recalled echo sequence using a partial echo (16 s total data acquisition, 
repetition time [TR] =4.7 ms, echo time [TE] =1.2 ms, flip angle =30°, field of view =40 
cm, bandwidth =24.4 kHz, matrix =128 × 80, 15-17 slices, 15 mm slice thickness). 3He 
MRI static ventilation images were acquired using a fast gradient echo method using a 
partial echo (14 s total data acquisition, TR/TE/flip angle =4.3 ms/1.4 ms/7°, field of 
view =40 cm, bandwidth =48.8 kHz, matrix =128 × 80, 15- 17 slices, 15 mm slice 
thickness). More details on MRI acquisition are provided in (3). 
3.2.1.3 3DCT Scan 
Thoracic multi-detector CT images were acquired with the same breath-hold volume and 
maneuver used for MRI. Patients were scanned in the supine position during inspiration 
breath-hold from FRC after inhaling 1L of N2 gas, using a multi-detector, 64-slice 
Lightspeed VCT scanner (General Electric Health Care, Milwaukee, WI) (64 mm × 0.625 
mm collimation, 120 kVp, 100 effective mA, tube rotation time = 500 ms, pitch = 1.0). A 
spiral acquisition was used and images were reconstructed using a standard convolution 
kernel to 1.25 mm slice thickness (3). 
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3.2.2 Biomechanical Model-based DIR 
The first step of the proposed CTVI is the deformable registration of the peak-respiration 
CT image pairs. We developed a patient-specific biomechanical model of the lung to 
simulate the lung motion and deformation. Reconstruction of the moving image was 
carried out using an FE-based algorithm that finds the deformation field on voxel-level 
based on nodal displacements of the FE model.  
3.2.2.1 Patient-specific Biomechanical Model of the Lung 
A biomechanical model was developed for each patient using data of their 4DCT image 
sequence. In the following, major components of the biomechanical model are described.  
The geometry of the lung at the relaxed state, i.e. at the EE phase, was used to generate 
the reference geometry. For this purpose, an automated segmentation algorithm was 
developed based on a Fast-Marching algorithm. The segmentation was validated using 
the radiation treatment planning contours provided by the radiation oncologist. The lung 
FE meshes with 8-node hexahedral elements (Figure 3-2) were generated using the IA-
FEMesh software package (Musculoskeletal Imaging, Modeling, and EXperimentation: 
MIMX, the University of Iowa, Iowa city, IA, USA) from the 3D lung model obtained 
from segmentation at the EE phase.  
The lung expansion from the reference geometry (at EE) to EI is attributed to 1) a drop in 
the transpulmonary pressure (originally caused by an expansion in the chest cavity), and 
2) the diaphragm contraction. Accordingly, to simulate the lung motion/deformation 
during respiration in a physiologically-realistic manner, we model these two mechanisms. 
To model the transpulmonary pressure, we are applying a negative pressure gradient on 
the surface of the mesh, with its amplitude described by:  
 𝑃(𝑦) = 𝑃1 + 𝑃2 × 𝑦, (1) 
where 𝑦 is the normalized anterior-posterior (AP) location of each surface element’s 
center of mass (0 ≤ 𝑦 ≤ 1). The parameters 𝑃2 and 𝑃1 are the linear gradient’s slope and 
the minimum pressure at the posterior-most location on the lung surface, respectively. 
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The assumption of having increasing pressure amplitude in the anterior direction is made 
to simulate patient’s breathing condition in supine position when the CT is acquired. 
Because accurate values for 𝑃1 and 𝑃2 are unknown for each patient (unless measured 
invasively), they are found through an inverse-problem formulation which aims at 
maximizing the modelling accuracy (the inverse problem is explained at the end of this 
section). To model the effect of the diaphragm contraction on the expansion of the lung, 
we extracted the deformation of the diaphragm-lung interface using a free-form 
deformable image registration algorithm. The displacement field at the diaphragm-lung 
interface is then applied to the bottom surface of the FE mesh as prescribed displacement 
Figure 3-2. Models geometry. The top row figures (a-1, b-1, and c-1) show the lung 
finite element meshes for the three patients at the end-exhale phase. The bottom row 
figures (a-2, b-2, and c-2) show the deformed geometries of the same cases after FE 
analysis. The mesh elements are color-coded according to the magnitude of 
displacements in mm.  
(a-1) (b-1) (c-1) 
(c-2) (b-2) 
(a-2) 
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boundary conditions (BCs) to model the lung expansion caused by the diaphragm 
activity. The quality of the treatment planning 4DCT is usually impaired by motion 
artifacts, especially around the diaphragm surface. To make sure our model is robust to 
changes in the image quality, we used our previously described method to correct for the 
underestimated diaphragm displacement field caused by motion artifacts (explained in 
Chapter 2).  Briefly, a correction factor, 𝜅𝐶𝐹(𝑦), was multiplied by the superior-inferior 
component of the displacement vectors obtained from free-form registration. 𝜅𝐶𝐹(𝑦) 
depends on the AP coordinate (𝑦) of the node where the displacement is applied, and it 
increases quadratically in the posterior direction. The minimum value of 𝜅𝐶𝐹 is 1, and its 
maximum value is optimized using the inverse-problem formulation described later in 
this section.  
The degree of freedom of the lung motion is limited in some surface areas (e.g. near the 
apex and in some areas of lung-ribs interfaces). We use a semi-automatic segmentation 
algorithm that extracts such surface areas that have very limited motion and constrain 
their degrees of freedom from the 4DCT image information for each patient (for more 
information, see Section 2.2.2.2). Fixed BCs were applied to the FE nodal points of those 
areas.  
As for the mechanical properties, taking into account the large deformation of the lungs 
during respiration and based on the results published in previous studies on lung 
parenchyma mechanical testing and material properties modeling (42,51,52), the lung 
tissue was modeled as hyperelastic, described by Yeoh strain energy density function 
(53). Where applicable, we segmented the tumor from the CT image at the EE phase, and 
identified the location of the tumor in the lung mesh. We modeled the tumor as linear 
elastic material. 
To estimate the patient-specific parameters of the lung biomechanical model that are not 
directly measured, i.e. the parameters defining the pressure (𝑃1 and 𝑃2) and 𝜅𝐶𝐹, an 
inverse-problem formulation was developed. This optimization step aims at maximizing 
the normalized mutual information (NMI) between the deformed image after the FE 
analysis and the target image (segmented lung at the EI phase), as well as minimizing the 
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distance between the simulated and actual lung surfaces. The same lung segmentation 
algorithm used for EE CT image was employed to segment the lung from the CT image 
at the EI phase. Details on the cost function, the initial values, and the convergence 
criteria are provided in Section 2.2.3. The optimized parameters are used to obtain the 
final displacement field for the FE mesh nodes. The optimization framework was 
developed in MATLAB (MathWorks, USA), and ABAQUS/Standard 6.14 (Dassault 
Systèmes Simulia Corp., Providence, RI, USA) was used as the FE solver.  
3.2.2.2 Image Reconstruction 
To calculate NMI during optimization and to reconstruct the deformed moving image 
(deformed EE image) after final FE analysis, we need to calculate the deformation field 
at the voxel-level from the displacement field defined at the FE mesh nodes. There exist 
interpolation techniques such as spline-based methods (thin plate spline, cubic spline, 
etc.) that can interpolate values at any point (voxels) from known function values at the 
control points (FE nodal points) (54–56). However, these methods can generate 
unrealistic and/or unphysical displacement fields (57). As an alternative approach, we 
utilized the FE shape functions defined for 8-node hexahedral elements to find the 
displacement of any voxel inside a given element from the displacements at the nodes of 
the element. The shape functions are defined as Lagrange interpolation in the element’s 
natural coordinates. This implies that to find the displacement of each voxel within an 
element from the nodal displacements, the location of the voxel in the corresponding iso-
parametric representation of the encompassing element is required. Although the 
transformation from the iso-parametric representation to the physical coordinates is 
known, the inverse mapping that is required to find the voxel’s natural coordinates is not 
trivial. We used a novel method designed and implemented by our group that finds the 
mapping from physical space to iso-parametric (natural) coordinates through an inverse-
problem formulation.  
3.2.2.3 Evaluation of the Biomechanical Model-based DIR 
The high accuracy of the biomechanical model for lung and tumor motion/deformation 
estimation was previously reported in Chapter 2 (see Section 2.3). To further evaluate the 
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performance of the proposed biomechanical model-based DIR algorithm for the patients 
included in this study, we identified approximately 40 landmark pairs at the bifurcation 
points on the EE and EI images. These landmarks were used to calculate the landmarks 
registration error (LRE). We also measured the Hausdorff surface-to-surface distance 
between the reconstructed and target lung surfaces.  
We compared the performance of our biomechanics-based registration with intensity-
based DIR. We used an off-the-shelf free form deformable registration algorithm to 
register the EE scan to the EI scan.  
3.2.3 Air Segmentation Algorithm 
In the proposed CTVI algorithm, the ventilation metric is defined as the change in the air 
volume at each voxel between EI and EE. After the registration step where the 
correspondence between the voxels in the EE and EI images is found, the amount of air 
in each voxel at both phases is required. For this purpose, we used a slightly modified 
version of an advanced thresholding algorithm previously developed in our lab (48). The 
accuracy of the air volume estimation is highly dependent on the values denoting air and 
tissue intensities. Therefore, instead of using fixed values of -1000 HU and 0 HU for air 
and tissue intensities, this algorithm finds patient-specific values to reduce the 
uncertainties associated with variable CT scanner parameters or image artifacts.  Firstly, 
two threshold values are initialized based on the combined histogram of EI and EE lung 
images (Figure 3-3) and are used to classify the voxels in the segmented lung images into 
3 groups: 1) entirely air voxels, 2) voxels containing air and soft tissue, and 3) entirely 
tissue voxels (Figure 3-3(a)). The threshold values were then optimized based on mass 
conservation law and soft tissue (e.g. alveoli wall tissue) incompressibility assumption. 
More details on the threshold initialization and optimization can be found in (48). The air 
volume in voxels in class #1 is the same as the voxel volume and is zero in class #3 
voxels. For voxels in the class #2, the partial volume of air (𝑃𝑉𝐴) in each voxel is 
calculated as:  
 
𝑃𝑉𝐴 = 
𝐼𝑡𝑖𝑠 − 𝐼𝑣𝑜𝑥
𝐼𝑡𝑖𝑠 − 𝐼𝑎𝑖𝑟
 ,  (2) 
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where 𝐼𝑎𝑖𝑟 and 𝐼𝑡𝑖𝑠 are the average intensity of the voxels in class #1 and #3, respectively. 
Multiplying 𝑃𝑉𝐴 with the voxel volume yields the air volume inside the voxel.  
We generate the air distribution maps for the segmented lung image at the EI phase, and 
the deformed EE image after registration using the air segmentation algorithm (Figure 
3-1). The high accuracy of the air segmentation algorithm has been demonstrated using 
both in-vivo and ex-vivo studies (48). 
3.2.4 Correcting for Regional Volume Expansion 
The air ventilation in the lungs is driven by two mechanisms, the regional volume 
expansion and the consequent increase in the amount of air. To obtain a physiologically 
relevant surrogate of ventilation using CT images, it is important to include the effect of 
both mechanisms. In the proposed CTVI algorithm, for the purpose of registration and to 
enable calculation of the change in the air volume, we reconstruct the deformed EE 
image with voxels corresponding to that of the EI image. Because the lung volume at the 
EI phase is larger, the deformed EE image is expanded to match that of the EI. Therefore, 
Figure 3-3. Finding initial thresholds for air segmentation. (a) The combined histogram 
of end-inhale and end-exhale histograms. The two initial thresholds divide the histogram 
to 3 regions, air only voxels, air combined with tissue voxels, and tissue only voxels. (b)  
The initial thresholds are found as points where the end-inhale and end-exhale 
histograms cross. 
(b) (a) 
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to obtain a more accurate estimation of the air volume at the EE phase, the amount of air 
found from the deformed EE image at each voxel using the air segmentation algorithm 
must be corrected by the ratio by which the volume was regionally expanded to match the 
EI image. We obtain the regional expansion ratio from the change in the volume of the 
mesh elements after analysis. As described in Section 3.2.2.2, we can locate the voxels 
inside the FE mesh by inversely mapping physical coordinates to the iso-parametric 
space. When the corresponding mesh element is found for a voxel, the regional expansion 
at that voxel is defined by: 
 
𝛼𝑣𝑜𝑥 = 
𝑉𝑜𝑙𝐸,𝑑𝑒𝑓
𝑉𝑜𝑙𝐸,𝑜𝑟𝑖𝑔
 ,  (3) 
where the 𝛼𝑣𝑜𝑥 is the volume expansion ratio for the voxel 𝑣𝑜𝑥, 𝑉𝑜𝑙𝐸,𝑑𝑒𝑓 is the volume of 
the mesh element 𝐸 after the FE analysis, and the 𝑉𝑜𝑙𝐸,𝑜𝑟𝑖𝑔 is the original volume of the 
mesh element 𝐸.  
3.2.5 Generating the CTVI 
Having the corrected air distribution map at the EE phase, and the corresponding air 
distribution map at the EI phase, we can obtain the CTVI from the difference in the air 
volume distribution. We also generated refined ventilation maps by lowpass filtering 
(Gaussian, 𝜎 = 1) and/or binning (3 × 3 × 3, full binning) the air distribution maps (both 
at EI and EE), to rectify the uncertainties caused by the small registration errors. 
3.2.6 Comparison of the CTVI with Hyperpolarized Gas MRI 
We used the 1H and 3He MR images available in the FLAIR dataset to compare our 
proposed CTVI with the MR ventilation. As described in Section 3.2.1, the breathing 
maneuver during image acquisition is different for treatment planning 4DCT and 3He 
MRI. The MR images were acquired during breath-hold at FRC + 1L, while the 4DCT 
scans were acquired at free breathing condition. To reduce the impact of the differences 
in the breathing maneuver and hence facilitate the comparison between the CTVI 
generated at the EI phase of 4DCT and the MRI, we used the breath-hold 3DCT 
(performed at the same volume as the 3He MR) to co-register the CTVI to MR images. 
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An off-the-shelf free-form deformable registration was used in Insight Toolkit (ITK; 
https://itk.org). 
To compare the CTVI with the 3He MRI quantitatively, we considered two categories of 
well-ventilated (> 25th percentile) and poorly ventilated (0th – 25th percentile) (58). We 
calculated the Dice similarity coefficient between the co-registered 3He MRI and CTVI 
for each of the poorly and well-ventilated regions.  
3.3 « Results » 
3.3.1 Biomechanical Model-based DIR Accuracy  
The accuracy of the proposed biomechanical model for lung and tumor 
motion/deformation has been previously validated (see Section 2.3). The FE-based 
reconstruction algorithm was evaluated by comparing the absolute difference image 
between the segmented lung images at EE and EI before, and after registration. The 
deformed EE images were reconstructed using the FE-based method described in Section 
3.2.2.2. Figure 3-4 illustrates the accuracy of the registration qualitatively, showing the 
EE image, EI image, reconstructed EE image, and difference images before and after 
registration for an arbitrary axial slice for one of the cases. We qualitatively compared the 
difference image after registration using our biomechanical model-based method and an 
off-the-shelf intensity-based DIR algorithm. Our biomechanical model-based DIR shows 
considerably higher performance.  
The deformed EE image was also reconstructed using thin plate spline (TPS) to compare 
its performance with that of the FE-based reconstruction. Beside the superior 
performance of the FE-based reconstruction over TPS closer to the lung peripheries 
where the TPS extrapolation generated unrealistic and non-physical deformation fields, 
the results were almost identical elsewhere. This highlights the importance of using the 
mechanics-based methods if a more accurate and finer displacement field at the voxel-
level from the FE mesh nodal displacements are desired. For quantitative assessment of 
the accuracy of the DIR method, LRE was calculated for each subject before and after 
registration using ~40 pairs of landmarks identified at bifurcation points (Table 3-1).  
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Table 3-1 Target registration error between EE and EI scans using ~40 landmarks, before 
and after FE-based registration. 
Patient # Before Registration (mm) After Registration (mm) 
1 8.30 ± 4.80 1.97 ± 0.58 
2 7.01 ± 4.50 2.35 ± 0.75 
3 8.81 ± 5.07 2.44 ± 1.05 
Figure 3-4. An example of the registration. (a) Moving image (EI), (b) target image 
(EE), (c) Resampled image (deformed EI image, to match EE), (d) difference image 
before registration, (e) difference image after registration using intensity-based DIR, and 
(f) the difference image after registration using biomechanical model-based DIR.  
(a) (b) (c) 
(d) (e) (f) 
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3.3.2 CTVI and Qualitative Comparison with 3He MRI 
The proposed CTVI algorithm was used to generate ventilation images for the 3 subjects. 
Figure 3-5 shows the 3He MRI overlaid on the proton MR (blue) and the corresponding 
CTVI overlaid on CT (heatmap). The coronal slices were chosen arbitrarily. As explained 
in Section 3.2.6, the MR scans are co-registered to the 4DCT and the figure shows the 
closest CTVI coronal slices to the MR slices after co-registration. The 3He MR images 
show the distribution of inhaled 3He gas in the lung and the CTVIs show distribution of 
air exchanged from EI to EE (i.e. ventilation). As shown in the Figure 3-5, the 3He MRI 
agrees well with the corresponding CTVI slices for all cases, while some discrepancies 
exist between them. The extent to which the 3He MR agrees with the CTVI appears to be 
(a-1) (a-2) (a-3) (a-4) (a-5) (a-6) 
(b-1) (b-2) (b-3) (b-4) (b-5) (b-6) 
(c-1) (c-2) (c-3) (c-4) (c-5) (c-6) 
Figure 3-5. Comparison of the 3He MR and CTVI, both overlaid on CT. Each row 
compares 3 coronal slices of one patient, (a) patient #1, (b) patient #2, and (c) patient #3.   
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different for each patient. For example, in patient #1 the agreement between the two 
modalities appear to be higher than that in patient #2. In addition, in all patients, the 
discrepancies mostly occurred in points closer to the inferior regions closer to the 
diaphragm, and in some cases at the top right. The disagreement between hyper polarized 
MR and CTVI in these lower regions has been shown to be attributed to differences in the 
breathing maneuver exercised when the images are acquired (58). The co-registration 
between the MR and 4DCT is conducted using an off-the-shelf intensity-based DIR, and 
therefore introduces some uncertainties to the 3He MR-CTVI comparison. The MR-
4DCT is responsible to reduce the impact of the difference in the breathing maneuver 
(a-1) (a-2) (a-3) 
(b-1) (b-2) (b-3) 
(c-3) (c-2) (c-1) 
Figure 3-6. Comparing the breathing maneuver. Rows (a), (b), and (c) correspond to 
patients #1, #2, and #3, respectively. The first column shows a slice of the 3DCT, taken 
at the same inspiration volume as MR, second column shows the corresponding slice on 
4DCT, acquired at tidal volume, and the third column is the absolute difference image of 
the two.  
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between the two modalities. Figure 3-6 shows the difference image between the 4DCT 
and the 3DCT (obtained at the same inspiration volume as MR). We can see some 
expansion at the top of the lung while the difference is the most predominant at and close 
to the diaphragm. Comparing the difference images of the patients, we can see that 
patient #3 shows the highest difference between the 4DCT inspiration volume and 3DCT 
(or MR) inspiration volume.  
3.3.3 Quantitative Comparison with 3He MRI 
The Dice similarity coefficients between the 3He MR and CTVI for each of the well- and 
poorly ventilated regions were calculated, as shown in Figure 3-7. Patient #1 shows the 
best agreement between the two modalities in both well-ventilated and poorly ventilated 
regions, while patient #3 shows the lowest agreement. The lower agreement for patient 
#3 compared to the other two cases can be attributed to the highest difference in the 
inspiration volumes of 4DCT and 3He MR. 
3.3.4 Discussion and Conclusions  
Lung ventilation imaging is of growing interest in the biomedical community for its 
potential to improve radiation therapy treatment planning, and hence the effectiveness 
Figure 3-7. The Dice similarity coefficient between 3He MR and CTVI for poorly 
ventilated and well-ventilated regions for the three patients. 
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and safety of radiation therapy for lung cancer patients. Due to the widespread use of 
4DCT for lung cancer therapy, incorporation of CTVI to radiation therapy treatment 
planning has become feasible. In this study, we proposed a novel CTVI technique that 
combines an accurate biomechanical model-based DIR with an advanced air 
segmentation algorithm. We validated the CTVI images generated using our proposed 
technique by comparing them with their hyperpolarized gas distribution map counterparts 
obtained using 3He MR imaging, both qualitatively and quantitatively.  
Firstly, we demonstrated good spatial agreement between the CTVI and 3He MR by 
comparing the images qualitatively. We observed some disagreements between the two, 
which can be attributed to the difference in the breathing maneuver that has been shown 
to largely impact the generated CTVI (58). In addition, it is noteworthy that 3He MR and 
CTVI are representatives of different surrogates of ventilation; 3He MR shows the 
distribution of 1L of hyperpolarized gas in the lungs that is inhaled from functional 
residual capacity (and held for 15 seconds) while CTVI maps the change in the local 
volume of air during tidal breathing. Considering that the 4DCT images and the MR 
images were taken approximately a week apart, the discrepancies are not expected to be 
related to disease progression.  
Unlike the CTVI algorithms that rely on intensity-based DIR, our algorithm was not 
sensitive to 4DCT image artifacts that happen near or on the diaphragm surface. This is 
because of the robustness of the biomechanical model-based DIR to the 4DCT artifacts, 
as explained in 2.3.2.  
This study is a proof of concept, performed on a small number of patients. The results of 
the study are promising and suggest that a larger scale study is required to further validate 
the outcome of this study. Furthermore, comparison of our CTVI algorithm against other 
available CTVI methods is an important step for validation. Until recently, there has not 
been a common validation tool for different CTVI techniques. Kipritidis et al. (27) 
recently published the results of a multi-institutional study for validation of CTVI 
methods (VAMPIRE study) using different reference modalities that are clinically 
accepted for ventilation imaging. Various CTVI methods from seven research groups 
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were included in this study, most of which used intensity-based DIR for registration of 
peak-respiration CT scans. The ventilation metrics included DIR-Jac, DIR-HU, and two 
hybrid ones.  The results of this study demonstrated that the extent of agreement 
(represented by measures of correlation or overlap) between different ventilation imaging 
modalities are not only dependent on the CTVI technique used, but also highly on the 
reference modality and the imaging subject (27). In this study, a biomechanics-based DIR 
that used the maximum principle stress as the ventilation metric showed highest 
correlation with nuclear medicine modalities (Galligas PET and DTPA-SPECT). The 
Dice similarity coefficients were reported as: median Dicelow = 0.52, range Dicelow = 
0.36-0.67, for low ventilation regions, and median Dicehigh = 0.45, range Dicehigh = 0.28-
0.62 (27). Although these values cannot be directly compared to the results of our study 
(different reference modality, different subjects and sample size, etc.), they demonstrate 
that the accuracy of our CTVI algorithm is similar to some of the best current CTVI 
algorithms and encourages future studies using our proposed CTVI technique. Finally, 
these findings highlight the promise of biomechanical models in DIR applications and 
their importance in advancing CTVI methods.  
«References» 
1.  Ireland RH, Tahir BA, Wild JM, Lee CE, Hatton MQ. Functional Image-guided 
Radiotherapy Planning for Normal Lung Avoidance. Clin Oncol [Internet]. 2016 
Nov [cited 2019 Jun 7];28(11):695–707. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/S0936655516302369 
2.  Fain SB, Korosec FR, Holmes JH, O’halloran R, Sorkness RL, Grist TM. 
Functional Lung Imaging Using Hyperpolarized Gas MRI. J Magn Reson Imaging 
[Internet]. 2007 [cited 2019 Jun 6];25:910–23. Available from: www.interscience. 
3.  Hoover DA, Capaldi DPI, Sheikh K, Palma DA, Rodrigues GB, Dar AR, et al. 
Functional lung avoidance for individualized radiotherapy (FLAIR): Study 
protocol for a randomized, double-blind clinical trial. BMC Cancer. 2014;  
4.  Marks LB, Spencer DP, Sherouse GW, Bentel G, Clough R, Vann K, et al. The 
99 
 
role of three dimensional functional lung imaging in radiation treatment planning: 
The functional dose-volume histogram. Int J Radiat Oncol [Internet]. 1995 Aug 
[cited 2019 Jun 7];33(1):65–75. Available from: 
https://linkinghub.elsevier.com/retrieve/pii/036030169500091C 
5.  Yamamoto T, Kabus S, Bal M, Keall P, Benedict S, Daly M. The first patient 
treatment of computed tomography ventilation functional image-guided 
radiotherapy for lung cancer. Radiother Oncol. 2016;  
6.  Yamamoto T, Kabus S, Von Berg J, Lorenz C, Keall PJ. Impact of four-
dimensional computed tomography pulmonary ventilation imaging-based 
functional avoidance for lung cancer radiotherapy. Int J Radiat Oncol Biol Phys. 
2011;  
7.  Faught AM, Miyasaka Y, Kadoya N, Castillo R, Castillo E, Vinogradskiy Y, et al. 
Evaluating the Toxicity Reduction With Computed Tomographic Ventilation 
Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017;  
8.  Vinogradskiy Y, Castillo R, Castillo E, Tucker SL, Liao Z, Guerrero T, et al. Use 
of 4-dimensional computed tomography-based ventilation imaging to correlate 
lung dose and function with clinical outcomes. Int J Radiat Oncol Biol Phys. 2013;  
9.  Huang Q, Jabbour SK, Xiao Z, Yue N, Wang X, Cao H, et al. Dosimetric 
feasibility of 4DCT-ventilation imaging guided proton therapy for locally 
advanced non-small-cell lung cancer. Radiat Oncol [Internet]. 2018 Dec 25 [cited 
2019 Jun 7];13(1):78. Available from: https://ro-
journal.biomedcentral.com/articles/10.1186/s13014-018-1018-x 
10.  Bradley J, Graham M V., Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity 
and outcome results of RTOG 9311: A phase I-II dose-escalation study using 
three-dimensional conformal radiotherapy in patients with inoperable non-small-
cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;  
11.  Ding K, Bayouth JE, Buatti JM, Christensen GE, Reinhardt JM. 4DCT-based 
100 
 
measurement of changes in pulmonary function following a course of radiation 
therapy. Med Phys [Internet]. 2010 Feb 24 [cited 2019 Jun 7];37(3):1261–72. 
Available from: http://doi.wiley.com/10.1118/1.3312210 
12.  Fain S, Schiebler ML, McCormack DG, Parraga G. Imaging of lung function using 
hyperpolarized helium-3 magnetic resonance imaging: Review of current and 
emerging translational methods and applications. Journal of Magnetic Resonance 
Imaging. 2010.  
13.  Kaireit TF, Gutberlet M, Voskrebenzev A, Freise J, Welte T, Hohlfeld JM, et al. 
Comparison of quantitative regional ventilation-weighted fourier decomposition 
MRI with dynamic fluorinated gas washout MRI and lung function testing in 
COPD patients. J Magn Reson Imaging [Internet]. 2018 Jun 1 [cited 2019 Jun 
7];47(6):1534–41. Available from: http://doi.wiley.com/10.1002/jmri.25902 
14.  Kirby M, Svenningsen S, Kanhere N, Owrangi A, Wheatley A, Coxson HO, et al. 
Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129 
magnetic resonance imaging: differences in COPD and relationship to emphysema. 
J Appl Physiol. 2013;  
15.  Harris RS, Schuster DP. Visualizing lung function with positron emission 
tomography. J Appl Physiol. 2007;  
16.  Petersson J, Sánchez-Crespo A, Larsson SA, Mure M. Physiological imaging of 
the lung: single-photon-emission computed tomography (SPECT). J Appl Physiol. 
2007;  
17.  Van Beek EJR, Wild JM, Kauczor HU, Schreiber W, Mugler JP, De Lange EE. 
Functional MRI of the lung using hyperpolarized 3-helium gas. Journal of 
Magnetic Resonance Imaging. 2004.  
18.  Mugler JP, Altes TA. Hyperpolarized 129Xe MRI of the human lung. Journal of 
Magnetic Resonance Imaging. 2013.  
19.  Ding K, Cao K, Fuld MK, Du K, Christensen GE, Hoffman EA, et al. Comparison 
101 
 
of image registration based measures of regional lung ventilation from dynamic 
spiral CT with Xe-CT. 2012 Jul 27 [cited 2019 Jun 6];39(8). Available from: 
http://dx.doi.org/10.1118/1.4736808] 
20.  Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. Utilization of 
Advanced Imaging Technologies for Target Delineation in Radiation Oncology. J 
Am Coll Radiol. 2009;  
21.  Socinski MA, Morris DE, Halle JS, Moore DT, Hensing TA, Limentani SA, et al. 
Induction and concurrent chemotherapy with high-dose thoracic conformal 
radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A 
dose-escalation phase I trial. J Clin Oncol. 2004;  
22.  Vinogradskiy Y, Castillo R, Castillo E, Chandler A, Martel M, Guerrero T. TU‐A‐
BRC‐11: Use of Weekly 4DCT‐Based Ventilation Maps to Quantify Changes in 
Lung Function for Patients Undergoing Radiation Therapy. In: Medical Physics. 
2011.  
23.  Vinogradskiy Y, Faught A, Castillo R, Castillo E, Guerrero T, Miften M, et al. 
Using 4DCT-ventilation to characterize lung function changes for pediatric 
patients getting thoracic radiotherapy. J Appl Clin Med Phys [Internet]. 2018 Sep 1 
[cited 2019 Jun 7];19(5):407–12. Available from: 
http://doi.wiley.com/10.1002/acm2.12397 
24.  Patton TJ, Gerard SE, Shao W, Christensen GE, Reinhardt JM, Bayouth JE. 
Quantifying ventilation change due to radiation therapy using 4DCT Jacobian 
calculations. Med Phys [Internet]. 2018 Oct [cited 2019 Jun 7];45(10):4483–92. 
Available from: https://doi.org/10.1002/mp.13105] 
25.  Yamamoto T, Kabus S, Bal M, Bzdusek K, Keall PJ, Wright C, et al. Changes in 
Regional Ventilation During Treatment and Dosimetric Advantages of CT 
Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer. 
Int J Radiat Oncol Biol Phys. 2018;  
102 
 
26.  Kipritidis J, Hugo G, Weiss E, Williamson J, Keall PJ. Measuring interfraction and 
intrafraction lung function changes during radiation therapy using four-
dimensional cone beam CT ventilation imaging. Med Phys. 2015;  
27.  Kipritidis J, Tahir BA, Cazoulat G, Hofman MS, Siva S, Callahan J, et al. The 
VAMPIRE challenge: A multi-institutional validation study of CT ventilation 
imaging. Med Phys [Internet]. 2019 Mar 1 [cited 2019 Jun 26];46(3):1198–217. 
Available from: http://doi.wiley.com/10.1002/mp.13346 
28.  Hegi-Johnson F, de Ruysscher D, Keall P, Hendriks L, Vinogradskiy Y, 
Yamamoto T, et al. Imaging of regional ventilation: Is CT ventilation imaging the 
answer? A systematic review of the validation data. Radiother Oncol [Internet]. 
2019 Aug 1 [cited 2019 Jun 12];137:175–85. Available from: 
https://www.sciencedirect.com/science/article/pii/S0167814019301148?via%3Dih
ub 
29.  Yamamoto T, Kabus S, Klinder T, von Berg J, Lorenz C, Loo BW, et al. Four-
dimensional computed tomography pulmonary ventilation images vary with 
deformable image registration algorithms and metrics. Med Phys [Internet]. 2011 
Feb 16 [cited 2019 Jun 7];38(3):1348–58. Available from: 
http://doi.wiley.com/10.1118/1.3547719 
30.  Yamamoto T, Langner U, Loo BW, Shen J, Keall PJ. Retrospective Analysis of 
Artifacts in Four-Dimensional CT Images of 50 Abdominal and Thoracic 
Radiotherapy Patients. Int J Radiat Oncol Biol Phys. 2008;  
31.  Vandemeulebroucke J, Bernard O, Rit S, Kybic J, Clarysse P, Sarrut D. Automated 
segmentation of a motion mask to preserve sliding motion in deformable 
registration of thoracic CT. Med Phys. 2012;  
32.  Rietzel E, Chen GTY. Deformable registration of 4D computed tomography data. 
Med Phys. 2006;  
33.  Han L, Dong H, McClelland JR, Han L, Hawkes DJ, Barratt DC. A hybrid patient-
103 
 
specific biomechanical model based image registration method for the motion 
estimation of lungs. Med Image Anal [Internet]. 2017 Jul 1 [cited 2019 Jun 
18];39:87–100. Available from: 
https://www.sciencedirect.com/science/article/pii/S1361841517300555 
34.  Fuerst B, Mansi T, Carnis F, Sälzle M, Zhang J, Declerck J, et al. Patient-specific 
biomechanical model for the prediction of lung motion from 4-D CT images. IEEE 
Trans Med Imaging. 2015;  
35.  Han L, Dong H, McClelland JR, Han L, Hawkes DJ, Barratt DC. A hybrid patient-
specific biomechanical model based image registration method for the motion 
estimation of lungs. Med Image Anal. 2017;  
36.  Werner R, Ehrhardt J, Schmidt R, Handels H. Patient-specific finite element 
modeling of respiratory lung motion using 4D CT image data. Med Phys. 2009;  
37.  Fuerst B, Mansi T, Zhang J, Khurd P, Declerck J, Boettger T, et al. A personalized 
biomechanical model for respiratory motion prediction. Med Image Comput 
Comput Assist Interv. 2012;  
38.  Al-Mayah A, Moseley J, Velec M, Brock KK. Sliding characteristic and material 
compressibility of human lung: Parametric study and verification. Med Phys. 
2009;  
39.  Al-Mayah A, Moseley J, Velec M, Hunter S, Brock K. Deformable image 
registration of heterogeneous human lung incorporating the bronchial tree. Med 
Phys. 2010;  
40.  Al-Mayah A, Moseley J, Velec M, Brock K. Toward efficient biomechanical-
based deformable image registration of lungs for image-guided radiotherapy. Phys 
Med Biol. 2011;  
41.  Al-Mayah A, Moseley J, Velec M, Brock K. Effect of friction and material 
compressibility on deformable modeling of human lung. In: Lecture Notes in 
Computer Science (including subseries Lecture Notes in Artificial Intelligence and 
104 
 
Lecture Notes in Bioinformatics). 2008.  
42.  Shirzadi Z, Sadeghi-Naini A, Samani A. Toward in vivo lung’s tissue 
incompressibility characterization for tumor motion modeling in radiation therapy. 
Med Phys. 2013;40(5):051902.  
43.  Han L, Dong H, McClelland JR, Han L, Hawkes DJ, Barratt DC. A hybrid patient-
specific biomechanical model based image registration method for the motion 
estimation of lungs. Med Image Anal. 2017;  
44.  Samavati N, Velec M, Brock K. A hybrid biomechanical intensity based 
deformable image registration of lung 4DCT. Phys Med Biol. 2015;  
45.  Simon BA. Non-invasive imaging of regional lung function using X-ray computed 
tomography. Journal of Clinical Monitoring and Computing. 2000.  
46.  Choi S, Hoffman EA, Wenzel SE, Castro M, Lin C-L. Improved CT-based 
estimate of pulmonary gas trapping accounting for scanner and lung-volume 
variations in a multicenter asthmatic study. J Appl Physiol [Internet]. 2014 Sep 15 
[cited 2019 Jun 6];117(6):593–603. Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/25103972 
47.  Castillo R, Castillo E, Martinez J, Guerrero T. TU‐B‐204B‐04: Ventilation from 
Four Dimensional Computed Tomography: Density versus Jacobian Methods. In: 
Medical Physics. 2010.  
48.  Moghadas-Dastjerdi H, Ahmadzadeh M, Samani A. Towards computer based lung 
disease diagnosis using accurate lung air segmentation of CT images in exhalation 
and inhalation phases. Expert Syst Appl. 2017;  
49.  Naini AS, Lee TY, Patel R V., Samani A. Estimation of lung’s air volume and its 
variations throughout respiratory CT image sequences. IEEE Trans Biomed Eng. 
2011;  
50.  Reinhardt JM, Ding K, Cao K, Christensen GE, Hoffman EA, Bodas S V. 
105 
 
Registration-based estimates of local lung tissue expansion compared to xenon CT 
measures of specific ventilation. Med Image Anal. 2008;12(6):752–63.  
51.  Sadeghi Naini A, Patel R V., Samani A. Measurement of lung hyperelastic 
properties using inverse finite element approach. IEEE Trans Biomed Eng. 2011;  
52.  Zeng YJ, Yager D, Fung YC. Measurement of the Mechanical Properties of the 
Human Lung Tissue. J Biomech Eng. 1987;  
53.  Yeoh OH. Some Forms of the Strain Energy Function for Rubber. Rubber Chem 
Technol. 1993;  
54.  Kvasov BI. Cubic Spline Interpolation. In: Methods of Shape-Preserving Spline 
Approximation. 2010.  
55.  Thévenaz P, Blu T, Unser M. Interpolation revisited. IEEE Trans Med Imaging. 
2000;  
56.  Bookstein FL. Principal Warps: Thin-Plate Splines and the Decomposition of 
Deformations. IEEE Trans Pattern Anal Mach Intell. 1989;  
57.  Schreibmann E, Pantalone P, Waller A, Fox T. A measure to evaluate deformable 
registration fields in clinical settings. J Appl Clin Med Phys. 2012;  
58.  Tahir BA, Marshall H, Hughes PJC, Brightling CE, Collier G, Ireland RH, et al. 
Comparison of CT ventilation imaging and hyperpolarised gas MRI: effects of 
breathing manoeuvre. Phys Med Biol [Internet]. 2019 Mar 7 [cited 2019 Jun 
7];64(5):055013. Available from: http://stacks.iop.org/0031-
9155/64/i=5/a=055013?key=crossref.c8bdad7ad8bb5ff8426576808c53baf5 
 
 
106 
 
Chapter 4  
4 « Conclusion and Future Work » 
In this thesis, we described the development of an accurate lung biomechanical model 
and its applications towards improving radiation therapy for lung cancer treatment. Two 
major applications of the model are tackled, including tumor motion/deformation 
compensation and CT based ventilation imaging. These applications were presented in 
Chapters 2 and 3 of this thesis. A summary and concluding remarks for each chapter are 
given below as closure.  
4.1 Chapter 2 
In Chapter 2, we described the development of a heterogeneous lung biomechanical 
model for motion and deformation estimation of the lung and the tumor. The accuracy of 
the proposed lung biomechanical model for tumor tracking was validated using measures 
of similarity and distance. In this study, we investigated the effect of incorporating the 
heterogeneities in the lung mechanics caused by COPD phenotypes on the tumor motion 
and deformation estimation accuracy. While the lung tissue homogeneity assumption for 
lung mechanics demonstrated fairly good performance for cases with less COPD severity, 
the heterogeneous tissue modeling alternative proved necessary to achieve high tumor 
motion/deformation estimation accuracies for cases that suffered from moderate to severe 
COPD. Another factor that influenced the accuracy gain achieved through utilizing the 
heterogeneous lung model is the proximity of pathological tissue to the tumor. The closer 
the pathological tissue to the tumor the higher the impact of utilizing the heterogeneous 
lung model. The results of the heterogeneous model for all cases showed promise of this 
biomechanical model for incorporation into radiation therapy applications, including but 
not limited to the biomechanics-based real time tumor tracking workflow designed by our 
group and explained in Section 1.3.5. 
The impact of incorporating COPD-induced heterogeneity on tumor motion and 
deformation accuracy was shown to be dependent on the extent and distribution of COPD 
phenotypes. Considering the higher computation time and cost of developing a 
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heterogeneous model compared to a homogeneous one for a patient, this observation 
encourages a study that aims at predicting whether a patient is likely to benefit from a 
heterogenous tissue model, or a homogeneous tissue model would provide sufficiently 
high accuracy, based on pertinent information from 4DCT.  
We acknowledge a number of limitations of this study. The number of patients included 
in this study was small. A larger scale study has to be carried out to further validate the 
observations of this study and more importantly to enable statistical analysis on the 
results (e.g. whether or not the improvement resulting from incorporating the tissue 
heterogeneous mechanical properties are statistically significant). To incorporate this 
model into a biomechanics-based real time tracking system, the FE analysis needs to be 
accelerated. This can be achieved through parallel processing using GPU architecture or 
by employing reduced FE model strategies to speed up the computation model 
processing. The training of a predictive model that facilitates tumor tracking using the 
information from chest surface motion data requires representation of the loading and 
boundary conditions in a compact form as explained in (1).  
4.2 Chapter 3 
In Chapter 3, we described the application of the heterogeneous lung biomechanical 
model in combination with an advanced air segmentation algorithm in generating 4DCT-
based ventilation maps. Since 4DCT has become part of the standard of care for lung 
cancer treatment in many centers, the proposed ventilation imaging algorithm has 
potential clinical applications for treatment planning. The potential higher resolution of 
CTVI compared to other ventilation imaging modalities can have clinical impacts for 
patients who are scheduled for intensity modulated radiation therapies and/or radiation 
therapy with ablative doses (SBRT) (2). The accuracy of the 4DCT ventilation maps were 
evaluated by comparison with 3He MR scans taken from the same patients. Results of 
qualitative and quantitative comparison of the 3He MR with our proposed CTVI 
technique are promising and warrant further investigation into improving its performance 
before carrying out a larger scale study.  
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We hereby acknowledge a number of the study limitations. Firstly, the small number of 
patients limits the statistical power of the study. A larger scale study that includes 
patients with different cancer stages, tumor locations/sizes, and comorbidity severities is 
required to further validate the findings of this study. In addition, SPECT is one of the 
reference modalities that is widely used for ventilation and it is important to compare our 
proposed CTVI and the acquired 3He MR against the SPECT scans of the same patients 
(3–8). The choice of the CTVI algorithm has also been shown to impact the results of 
comparison with the reference modalities (9–12). Therefore, different CTVI algorithms 
should be used and compared against each other and the reference modalities (such as He 
MR or SPECT) to determine which CTVI method offers better physiological 
correspondence with SPECT or He MR scans.  
Ventilation is only one surrogate for lung function. In functional avoidance planning 
applications, it is important to also consider other representations of lung function, 
including perfusion and diffusion (4,13–18). Ventilation to perfusion ratio in particular is 
an important representation of lung function that can be used to improve functional 
avoidance planning (13,19). Therefore, for functional avoidance therapies it is important 
to complement the information obtainable from ventilation imaging (e.g. from CTVI) 
with maps of distribution of perfusion and/or diffusion to have a more accurate and 
realistic assessment of lung regional function.  
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